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Introduction, Aims and Outline
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Chronic gastrointestinal ischemia is considered to be a rare disease. It is referred to as
chronic mesenteric ischemia, abdominal angina, or chronic splanchnic syndrome. Its
diagnosis is notoriously difficult and mainly relies on clinical presentation, exclusion of
other diagnoses, and angiography as final diagnostic modality 2,8. Typical symptoms,
including postprandial pain, fear of eating, and weight loss, combine in a condition
referred to as chronic splanchnic syndrome or chronic mesenteric ischemia.
Angiography as well as most if not all other currently available diagnostic tools (such as
duplex sonography, CT- and MR-angiography) have in common that they provide
information about vessel anatomy, vessel patency or blood flow, but not about end-
organ ischemia. However, in the gastrointestinal tract it is crucially important to be
informed not only about the presence of vascular stenoses but about presence or
absence of ischemia as well, because many patients with splanchnic stenoses remain
asymptomatic and thus have no indication for treatment. In other words: detection of a
stenosis alone does not prove ischemia 6,7,15.
Because of the extensive collateral circulation between its three main arterial branches
(celiac artery (CA), and superior (SMA) and inferior (IMA) mesenteric artery), it is
widely recognized that the gastrointestinal tract is resistant to ischemia 12,13. Many
authors have stated that at least two of the three major splanchnic arteries have to be
stenotic or occluded to give ischemic symptoms. But studies that reported the rarity of
an isolated stenosis of CA as cause of complaints 5,14 are in contrast with series showing
disappearance of symptoms after treatment of isolated CA stenoses 10,11.
As some but not all patients with splanchnic stenoses benefit from treatment the main
question is therefore how to chose who to treat and who not to treat. It was already
acknowledged over a decade ago that “a functional and physiological test distinguishing
symptomatic ischemia, the chronic splanchnic syndrome from non-ischemic stenoses,
the chronic splanchnic disease, was urgently warranted” 1.
Measurement of gastrointestinal intraluminal PCO2 by means of tonometry has been
shown to provide exactly that information: the presence or absence of ischemia.
Gastrointestinal tonometry is until now the only clinically feasible, i.e. minimally
invasive and bedside, technique for monitoring of the adequacy of gastrointestinal
(mucosal) perfusion.
Uncertainties about the physiological background, methodology, and clinical use
hampered tonometry from gaining the status of a routine diagnostic technique.
However, most of its initial methodological problems have been addressed and solved,
for instance by the introduction of automated air tonometry. In chapter two an update
on the current thoughts on tonometry is given.
Gastric tonometry after food provocation has been used as diagnostic test for chronic
gastrointestinal ischemia. This has resulted in varying and disappointing accuracies 1,3,4,9.
Using physical exercise as an alternative provocative manoeuvre, gastric tonometry
showed to be a promising test for the detection of symptomatic chronic gastrointestinal
ischemia 9. Uncertainties arising from this pilot study were the intensity of exercise
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needed for provocation of gastrointestinal ischemia, the best way to monitor this
exercise intensity and the best location in the GI tract for tonometric measurements.
In chapter three the influence of exercise intensity on gastric mucosal perfusion
adequacy as measured by tonometry is investigated in a volunteer study with two
different (submaximal and maximal) exercise levels.
In chapter four different monitoring regimes (heart rate monitoring, respiratory gas
exchange ratio -RQ-, and rapid serial arterial lactate measurements) for determining
exercise intensity are compared.
In chapter five the first results of small bowel tonometry are presented. Our concern
has been that measurement in the stomach alone (perfused by the celiac artery) might
cause false-negative tonometry results in patients with stenoses in the superior
mesenteric artery, supplying the small bowel. Therefore, we performed exercise
tonometry tests with an additional tonometer positioned beyond Treitz’s ligament. The
results of small bowel tonometry were compared with measurements in the stomach.
In chapter six gastric exercise tonometry testing is validated as a diagnostic tool in a
cohort of patients suspected for chronic gastrointestinal ischemia.
In chapter seven we retrospectively evaluate three potential diagnostic regimens for
suspected chronic gastrointestinal ischemia, yielding a novel approach for the workup
of these patients.
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ABSTRACT
Gastrointestinal luminal PCO2 tonometry has been introduced in critically ill patients, to
derive the mucosal pH (pHi) as a measure of mucosal perfusion adequacy, from the
regional, luminal PCO2 determined with help of a balloon-tipped and saline or air-filled
tonometer, and the blood bicarbonate content. Some physiological, methodological and
clinical aspects of gastrointestinal PCO2 tonometry remain unclear. Recent literature
suggests that, as expected from normal physiology, the blood-tonometer balloon PCO2
gradient is a more specific and sensitive indicator of mucosal hypoperfusion than the
pHi, even though the threshold of the PCO2 gradient that indicates the onset of tissue
anaerobic metabolism is unclear. Otherwise, gastric buffering of acid by bicarbonate,
derived from feeding or entering the stomach from the duodenum, can elevate luminal
PCO2 independently from mucosal PCO2, and experiments indeed suggest that acid
secretion suppression may increase the validity and utility of the technique. Some
sources of error inherent to the manual saline tonometry technique are circumvented
by the recently developed semi-continuous automated air tonometry technique in the
stomach, that has been proven to give reliable results clinically. The value of tonometry
in small and large bowel is being explored. The evidence that tonometric derived
variables are prognostically important, in terms of predictive value for morbidity and
mortality in a variety of conditions, even more so than global haemodynamic variables,
is accumulating, but controversy remains whether the PCO2 gradient is superior to the
pHi in this prediction. Taken together, wider knowledge of the physiological
background and sources of error of tonometry may widen the clinical applicability of
the technique by which regional perfusion adequacy can be assessed non-invasively and
which can be used on a routine basis to guide treatment of critically ill patients with
hypoperfusion.
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Figure 1. Principle of gastric tonometry (reproduced with permission from the editor:
J.A. Otte et al. PCO2 tonometrie van de maag. Ned Tijdschr Geneesk 2000;144(49):2341-5)
Chapter 216
Gastrointestinal mucosal pH (pHi), calculated from the tonometrically measured PCO2
in the gastrointestinal lumen and the blood bicarbonate content using the Henderson-
Hasselbalch equation, has been suggested to constitute an index of the adequacy of
splanchnic mucosal perfusion. This may relate to the prognosis of critically ill patients,
as bowel wall hypoperfusion may result in tissue injury, increased permeability,
endotoxin-bacterial translocation and a harmful inflammatory (cytokine) response
11,12,26,30,37,54,62,68,71,73,99,107,115,123,131,132. The theory is that hypoperfusion below a critical
level causes tissue (mucosal) carbon dioxide accumulation and acidosis. As carbon
dioxide diffuses easily across membranes, the PCO2 in the gut lumen also increases,
leading to widening of the blood-tonometer PCO2 gradient. In fact, the pHi has been
used successfully to guide treatment and to improve the outcome of critically ill patients
36,46,49,62,68. Nevertheless, tonometry has not yet become a routine intensive care
monitoring technique. This may relate to uncertainties regarding the physiological
background, the methodology, and the clinical usefulness 46. This review will therefore
update current thoughts on these aspects 36,46.
PHYSIOLOGICAL BACKGROUND
Gastrointestinal hypoperfusion
Several conditions may lead to altered gut perfusion (Table 1). Haemorrhagic hypo-
tension, cardiac tamponade, cardiac bypass or vasopressin infusion for example, may
lead to mucosal hypoperfusion along the entire gastrointestinal tract, and this may be
assessed with the help of simultaneous tonometric measurements in various gastro-
intestinal segments 1,83,85,102,118,119,135. In fact, the bowel PCO2 gradient may increase and
pHi decrease during hypoperfusion states, similar to changes in gastrically determined
tonometric variables. This may also apply to sepsis and shock, even if the oxygen
demands by the bowel wall increase 102, and to cardiopulmonary bypass surgery, during
which bowel wall oxygen demands may decrease following hypothermia and increase
during rewarming 3,11,29,53,107,111,112,130. Moreover, shock may result in early selective
splanchnic vasoconstriction so that gastric tonometry may yield an early indicator of
general hypoperfusion 33,36,46,55,102,135 . The gastric tonometric PCO2 gradient proved an
early, sensitive indicator of hypovolaemia during haemorrhage in healthy volunteers 55.
An increase in the gastric PCO2 gradient and decrease in pHi during general
hypoperfusion in humans may relate to angiotensin II-induced selective splanchnic
vasoconstriction 67,110.
Experimental studies utilizing vascular occlusion and reperfusion, induction of shock or
pharmacological splanchnic vasoconstriction have revealed that changes in blood flow
to the gut wall, as measured by microspheres, laser Doppler, electromagnetic or ultra-
sonic flow probes, or reflectance spectrophotometry, were paralleled by concordant
changes in tonometric variables 2,57,70,73,83,85,102,109,116,118,119,120,126,132,135. A decrease in
blood flow to less than 50 % of baseline during incremental hypoperfusion leads to an
increased tonometric PCO2 relative to supplying (and draining) blood values. This
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results in a decrease in pHi, in parallel with the decreasing blood flow and the fall in
tissue PO2 and oxygen consumption 1,2,13,36,46,50,55,57,73,83,85,102,104,109,116,118,119,120,126,135. This
may result in tissue damage and increased mucosal permeability 1,11,12,26,71,73,107,123,132. In
critically ill, septic, and mechanically ventilated patients, laser-Doppler (and reflectance
spectroscopy) measurement of gastric mucosal blood flow, hepatosplanchnic blood
flow measured by indocyanine green, or hepatic breakdown of injected lidocaine to
monoethylglycinexylidide, were lower in patients with an increased PCO2 gradient and
subnormal pHi than in those without these tonometric abnormalities, or in healthy
controls 35,94,103,128. In fact, drug-induced changes in blood flow assessed by these
techniques can be paralleled by concordant changes in the PCO2 gradient and
pHi 34,94,102,103,128.
Table 1. Conditions in which tonometry is of potential clinical value.
Perioperative monitoring in major surgery, including cardiopulmonary bypass,
major (emergency) vascular surgery and liver transplantation
Myocardial infarction and shock
Heart failure
Pulmonary embolism and shock
Traumatic/hypovolaemic shock
Sepsis and shock
Pericardial tamponade
Fluid and drug therapy for shock
Infusion of vasopressin or other vasoconstrictors
Acute pancreatitis
Mesenteric thrombosis
Necrotizing enterocolitis
Ischaemic colitis
Bowel obstruction
Chronic celiac and mesenteric vascular disease
Assessment of bowel viability
Intolerance to tube feeding
Weaning from mechanical ventilation
Haemodialysis
However, tonometric variables are indicators of the blood flow to demand ratio.
Changes in splanchnic blood flow, as assessed by the indocyanine green clearance or
laser Doppler techniques, are not necessarily accompanied by changes in tonometric
variables and vice versa, particularly when demand changes, for example with the
variation in body temperature associated with cardiopulmonary bypass surgery and
sepsis. During hypothermic cardiopulmonary bypass surgery, gastric mucosal (Doppler)
blood flow may decrease, but neither the gastric luminal to blood PCO2 gradient nor the
pHi may change 3,107,115. The generally observed fall in pHi during rewarming and in the
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postoperative phase may not concord with splanchnic blood flow changes and oxygen
consumption, which may even increase, and this discrepancy suggests either an
increased oxygen demand, or insufficient ability of pHi to reflect the balance between
oxygen supply and demand 53,107,110,111,115,130. Even during normothermic
cardiopulmonary bypass surgery, bowel demands may increase and may be
insufficiently met by an increase in blood flow, thereby lowering the pHi 53. Discordant
changes in cardiac output and gut blood flow on the one hand and tonometric variables
on the other during treatment with catecholamines, with an increase in the former but
no improvement in the latter, may relate in part to redistribution of blood flow within
the stomach or gut wall, away from the mucosa 11,111,112,128,130. During endotoxaemic-
septic shock, gut blood flow may not decrease and gut PO2 and oxygen consumption
may increase, but this may not prevent a subnormal gastrointestinal pHi developing,
suggesting redistribution of blood flow, impaired oxygen use, or both 132. Finally, it
remains to be seen if deterioration in tissue oxygenation and increased anaerobic
metabolism through severe hypoxemia or anaemia also result in tonometry changes 70
as it is conceivable that a high blood flow but insufficient oxygen delivery may limit the
increase in PCO2 and decrease in pHi 3.
Sublingual, oesophageal, gastric, and bowel PCO2 tonometry
Luminal production of carbon dioxide during buffering of gastric acid by bicarbonate
or bacterial fermentation may limit the specificity of the luminal PCO2 and thus the pHi
as indicators of the adequacy of mucosal perfusion in the stomach and large bowel,
respectively. This may not occur with tonometry in the oesophagus or sublingually as
these areas are not supplied by splanchnic blood vessels. Thus the sensitivity of
tonometry for early detection of general hypoperfusion may be inferior to that for
detecting hypoperfusion in the stomach or small bowel, where selective
vasoconstriction may occur 33. During severe haemorrhage or sepsis in animals,
sublingual, oesophageal and gastric PCO2 nevertheless increased in parallel and
simultaneously with the decrease in blood flow and increase in blood lactate
concentration 52,64,101,119,124. With regard to the value of small bowel tonometry vs.
gastric tonometry, widening of the tonometer-blood PCO2 gradient in pigs may be
earlier in the small bowel than in the stomach during haemorrhagic shock, but not
during cardiac tamponade 1. The increase in jejunal PCO2 during endotoxaemia in
horses was less and occurred later than that of the gastric PCO2 125. Walley and
colleagues 135, showed that during haemorrhagic hypotension, widening of the
tonometer-blood PCO2 gradient was less variable in the jejunum than in the stomach,
largely because of greater measurement error in the latter.
PCO2 gradient vs. pHi as an indicator of mucosal hypoperfusion
It has been argued repeatedly that pHi is a composite variable, consisting of a systemic
and locally derived variable, and should be replaced by the blood-tonometer PCO2 (or
perhaps pH) gradient. This is especially so if tonometry is being done to yield a sensi-
tive and specific measure of the adequacy of gastrointestinal mucosal perfusion, inde-
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pendent of systemic metabolic and respiratory alterations 26,42,46,51,55,62,63,64,73,88,121,135.
Indeed, the major pitfall in the calculation of the pHi from gastric PCO2 and the arterial
bicarbonate content is the assumption that the latter equals mucosal content. In
humans, the mucous layer of the acid-secreting stomach also contains bicarbonate,
which is secreted by non-parietal cells and helps to protect the underlying mucosa from
the gastric acid secreted by parietal cells 69. Mild hypovolaemia in human volunteers
decreases gastric bicarbonate secretion more than acid secretion, and this may be
associated with alterations in the tissue bicarbonate concentration 69. Hence, the
bicarbonate content of the mucosa may be normally higher than in blood, while
hypoperfusion may result in a dissimilar decrease in blood and mucosal bicarbonate
content, depending on the balance between general and regional hypoperfusion,
diminished bicarbonate secretion, and the degree of buffering of lactic acid in the
hypoperfused stomach wall 73,116,120,126. Conversely, changes in arterial blood
bicarbonate content may lead to alterations in calculated pHi, independent of changes
in the degree of mucosal hypoperfusion and the increase of the PCO2 gradient 121.
Intravenous bicarbonate administration to a patient with mesenteric thrombosis
resulted in an increase of gastric tonometer pHi to normal values, despite a necrotic
bowel later found at laparotomy, but the stomach may not have represented the small
bowel 10. Conversely, in cardiac surgery patients, a rapid decrease in arterial bicarbonate
content by volume loading during surgery may contribute to a lowered gastric pHi,
independently of luminal PCO2 5.
Moreover, gastric PCO2 closely parallels local arterial (and draining venous) blood PCO2
values during changes in alveolar ventilation, as demonstrated in animals and human
volunteers with (presumably) normal perfusion, so that changes in pHi may result from
changes in alveolar ventilation, independent of mucosal hypoperfusion 13,27,31,80,118.
Conversely, changes in alveolar ventilation in patients undergoing mechanical
ventilation resulted in changes in tonometric variables similar to blood PCO2, if gastric
mucosal blood flow remained adequate 13,31. The dependency of pHi on arterial blood
bicarbonate content and PCO2 may underlie the observed concurrent changes or
correlations between calculated pHi on the one hand and acid-base variables, including
lactate concentration, on the other 19,31,41,49,62,84,136.
It is still unclear as to the threshold for anaerobic metabolism, but the upper limit of a
normal gradient would be approximately 1.2 kPa 80,88,116,127. The increased luminal PCO2
during hypoperfusion is assumed to stem from two sources. With a moderately gradual
reduction in perfusion, mucosal PCO2 accumulates after a reduced washout and an
increase in tissue and venous PCO2. A further decrease in blood flow results in a steep
increase in tissue (luminal) and to a lesser extend venous PCO2 and this may be caused
by buffering of anaerobically produced lactate and protons by mucosal bicarbonate
57,73,116,120,135. Hence, a gradient between tissue and draining venous PCO2, in spite of
allegedly high diffusibility of carbon dioxide, may be a marker of anaerobic tissue
metabolism. It seems that a fall in tissue oxygen consumption and tension and develop-
ment of anaerobic metabolism and production of lactic acid occurs at a PCO2 gradient
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of 3.3 kPa or greater, a value that can be regarded as the critical gradient 2,36,116,120,135. A
lower gradient, however, does not exclude a focal oxygen deficit in the mucosa 80. The
baseline PCO2 tonometer-blood gradient in patients with gastric erosions or ulcerations
and stenotic or occluded celiac and mesenteric vessels at angiography was about 0.4 kPa
and rose to about 2.5 kPa during submaximal exercise, whereas no such increase was
observed in patients with a normal angiography 78. Thus, some patients had lesions in
the stomach attributable to hypoperfusion in spite of a resting PCO2 gradient
presumably below the critical value of approximately 3.3 kPa 78. The lesion may relate
to intermittent or patchy hypoperfusion rendering the mucosa susceptible to damage by
other factors.
METHODOLOGICAL CONSIDERATIONS
Comparison of tonometric with directly measured variables
In the control state, tonometric pHi may agree with directly measured tissue pH in the
stomach and bowel 40. Some authors have shown that the directly measured PCO2 is
higher than the tonometrically derived PCO2, and that the response time of the latter is
slower 36,104. This may result in tonometric pHi overestimating directly measured tissue
pH during sudden hypoperfusion 2,36. The latter may also relate to the erroneous
bicarbonate assumption discussed above.
Normal values
Normal values for gastric tonometry have been defined, taking in vivo determined
correction factors and blood-gas analyzer bias (see below) into account 80. The upper
limit of normal values for PCO2 was 6.5 kPa and for the tonometer to blood PCO2
gradient 1.2 kPa, so that, tonometric PCO2 is a few kPa higher than in the blood supply.
The lower limit of normal for pHi is 7.33 and for the pH gradient -0.06 80. This may
partly agree with other reports, wherein the upper limit of normal pH varied between
7.32 and 7.35 12,19,30,35,49,59,60,65,68,80,84,90,99,100,109,127. Data on normal PCO2 or the PCO2
gradient in the human gut are lacking. Bass et al. noted that the control intestinal
(jejunal or ileal) mass spectrometer PCO2 was 11.9 kPa in dogs, but arterial values were
not given 9. The normal fiberoptic/tonometric ileal to blood PCO2 gradient may, as in
the stomach, amount to 1.3-2.7 kPa in pigs and dogs 73,83,103,116,120. The normal
oesophagus to blood PCO2 gradient is also in that range 52,83. There is no information
on the normal tonometer balloon equilibration characteristics from the oesophagus to
large bowel, where changes in luminal contents and diffusion conditions may have an
effect.
Gastric PCO2 as a measure of gastrointestinal mucosal PCO2
It is generally assumed that rapid diffusion results in luminal PCO2 being identical to
mucosal PCO2. Nevertheless, the increase in tonometric PCO2 may underestimate that
of directly measured PCO2 39,104. Carbon dioxide diffuses rapidly from mucosa into the
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lumen with complete equilibration in 60 minutes, while diffusion in the opposite
direction is about four times slower 38. Even though carbonic anhydrase, present in the
gastric mucosa, may contribute to the difference in diffusion rate, inhibition of carbonic
anhydrase activity did not decrease the rate of PCO2 build-up in the tonometer
balloon 75. This suggests that the balloon PCO2 arises from gastric contents as opposed
to the gastric mucosa. Indeed, gastric carbon dioxide content may decrease by 6 % and
PCO2 may decrease by 0.3 kPa during equilibration of 1.5 ml of tonometer balloon
saline, in the absence of transmucosal diffusion 75. Gastric balloon rather than
transmucosal carbon dioxide diffusion may be the rate limiting step during gastric PCO2
tonometry 75.
Gastric secretion of acid
The close approximation of luminal and mucosal PCO2 may be lost in the stomach
when carbon dioxide is produced by buffering of gastric acid, contributing to a
relatively poor reproducibility of gastric pHi 135. Indeed, in the normally perfused upper
gastrointestinal tract, luminal PCO2 may directly relate to the amount of acid secreted
and buffered in the stomach, and has even been used as measure of acid
secretion 106,117. This luminally produced carbon dioxide stems from the buffering of
gastric acid by bicarbonate secreted by the gastric mucosa or by bicarbonate entering
the stomach through duodenal reflux or from saliva via the oesophagus 106. The
increase in PCO2 resulting from buffering can be prevented by inhibition of acid
secretion 38,106. Hence it has been recommended to perform tonometry H2 block of
gastric acid secretion 36,46. In fact, gastric PCO2 in human volunteers is 1.3-2.7 kPa
above blood levels and decreases towards arterial levels with less interindividual
variation after inhibition of acid secretion by the H2 blocker ranitidine, so that
calculated pHi is higher in the presence of prior H2 block 77,113,127. When duodenogas-
tric reflux is simulated by oral administration of bicarbonate in an amount approxima-
ting the hourly pancreaticoduodenal production, gastric PCO2 increases to
approximately 10.7 kPa above blood levels but only in the absence and not in the
presence of prior H2 block 77. Removal of gastric acid by suction may not decrease gas-
tric PCO2 towards blood values 113. This can be explained by the fact that gastric acid,
which is produced in the deep pits of the gastric mucosa, is buffered by gastric
bicarbonate in the mucus layer covering these pits 77. Buffering of gastric acid by
administration of non-CO2 releasing antacids like aluminium oxide-magnesium
hydroxide also releases large amounts of carbon dioxide in vitro and is therefore not
useful 133.
It can be questioned whether data in healthy subjects would apply to critically ill
patients as H2 blockers, which could be expected to lower PCO2, had no effect on
gastric PCO2 in the seriously ill 22. Together with the concept that inhibition of acid
secretion may predispose to gastric bacterial colonization and nosocomial infections,
this may be the reason that many authors do not use H2 block before tonometry in
critically ill patients 17,31,34,110,111,112,122,130. Similarly, administration of sucralfate, which
has acid-buffering capacities and increases gastric bicarbonate secretion, and could
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therefore be expected to increase PCO2 in the presence of acid, had no effect on the
PCO2 in critically ill patients 21. This may be explained by a reduction in gastric acid
secretion, as shown by a relatively high gastric juice pH that fails to decrease after
pentagastrin infusion in many critically ill patients after operation 5,44,60.
During the first 24 h after cardiopulmonary bypass surgery, gastric fluid may be acidic
(pH<4.0) in a minority of patients 5. Simulation of duodenogastric reflux by gastric
bicarbonate administration had no effect on gastric PCO2 immediately after surgery,
indicating lack of gastric acid secretion but increased gastric PCO2, on the first
postoperative day by 2.7 kPa in six of 10 subjects 5. The observations suggest
postoperative recovery occurs after reduced gastric acid secretion caused by transient
hypoperfusion.
Indeed, gastric acid secretion is an active, energy-demanding process 69. During
haemorrhagic hypotension, gastric mucosal blood flow and gastric acid (and
bicarbonate) secretion diminish, but less so in pentagastrin- or histamine-stimulated
conditions than in animals pre-treated with H2 blockers 69. This suggests that gastric
acid secretion in shock is blood flow dependent and that administration of H2 blockers
(or proton pump inhibitors) may further diminish energy-demanding gastric acid
secretion and blood flow and may protect against development of stress ulcers related
to hypoperfusion 66,69,93. In fact, a low pHi may be associated with failure to acidify the
gastric lumen in response to pentagastrin 65. The combination of a reduced demand and
an increased perfusion reserve during inhibition of acid secretion probably results in a
lowered sensitivity of tonometry as an indicator of early perfusion failure or gastric
mucosal hypoperfusion. A patient who develops an increased PCO2 gradient might
either have mucosal hypoperfusion or recurrence of gastric acid secretion after
amelioration of hypoperfusion. Inhibition of acid secretion reduces the incidence of
this dilemma, and simple measurement of gastric juice pH, preferably by continuous
monitoring, could solve the problem. An aspirated juice pH above 4.0-5.0, checked
with the help of litmus paper, would suggest minimum or no buffering effects 5,67,86,127,
so that changes in gastric PCO2 would probably the result from changes in mucosal
perfusion only.
However, H2 blockers such as ranitidine may fail to control gastric juice pH, even in
critically ill patient 98. The efficacy of the first dose after i.v. administration is reduced
within 24 h 96, and after 48 h, the gastric juice pH is again less than 4.0 for 60% of the
time 44. The proton pump inhibitor omeprazole increases gastric juice pH more
efficiently and continuously than H2 antagonists, even 24 hours after administration 96.
While abolishing acid and inhibiting bicarbonate secretion, the drug may maintain
mucosal perfusion, in contrast to H2 blockers that may decrease both acid secretion and
mucosal blood flow 93. Preserved blood flow after proton pump inhibitors may
contribute to prevent stress ulcer bleeding during haemorrhagic hypotension 66.
Tonometry in fed or fasting state?
Eating a meal might serve as a stress test for mucosal vasodilator reserve as the meal
stimulates gastric acid secretion, and small bowel secretions, and active resorption of
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nutrients. The increased energy expenditure of the gut causes an increase in blood flow
to the stomach and small gut mucosa 85. Indeed, luminal PCO2 may increase to 53.5 kPa
in the normal stomach and duodenum after gastric feeding, as a result of buffering of
the increased acid by the increased bicarbonate output 117. As the increased post-
prandial PCO2 is caused by acid buffering, it might be expected that acid suppression
could circumvent this increase. However, although H2 antagonists can effectively block
basal or fasting acid secretion, the suppression of meal-stimulated gastric acid secretion
may be incomplete, even in critically ill patients 98. Even in the presence of H2 blockers,
gastric feeding of critically ill patients may increase the gastric PCO2 relative to blood
values, presumably as a consequence of the production of carbon dioxide 77,91. This
may also occur in some individuals where acid secretion has been inhibited completely
by a combination of ranitidine and the muscarinic receptor antagonist pirenzepine 76,98.
The cause of this increase proved to be the buffering of the amino acid-containing food
by gastroduodenal bicarbonate 76,91. PCO2 may also decrease shortly after gastric feeding
because of dilution. Hence the volume of food given and the gastric emptying rate
determine this dilution effect 76. Finally, when the reserve in cardiac output is limited, a
meal may increase blood flow in the proximal gastrointestinal tract while diminishing
blood flow and pHi in the distal gastrointestinal tract 85. Hence, normal tonometry
variables after a meal do not exclude gastrointestinal hypoperfusion. Taken together, it
is recommended to perform gastric tonometry in the fasting state as this may increase
specificity, even though it may decrease the sensitivity of the method 36,46,47,76,77,91.
Alternatively, duodenal feeding may affect gastric tonometry less than gastric feeding.
Confounding factors
In the colon, carbon dioxide production by bacteria may lead to a lower normal pHi
than in the stomach 12,37. Indeed, normal colonic PCO2 may amount to 40 kPa,
depending on the diet 20. In horses, who have a large bacterial flora and eat almost
exclusively carbohydrates, the normal colonic PCO2 was >26.7 kPa 125. These obser-
vations should prompt collection of data for normal values of colonic PCO2 or the
effects of bowel preparation, laxatives or antibiotics, as sigmoid tonometry has been
reported to be of value in aortic surgery patients. Entry of environmental air into the
stomach may transiently lower gastric PCO2 20. Hence a negative gradient may indicate a
measurement artefact. This occurs particularly in non-intubated, spontaneously
breathing patients.
Sources of error during manual fluid tonometry
Manual fluid (usually saline) PCO2 tonometry is laborious and involves seven steps, each
carrying a risk of error so that reproducibility may be relatively poor (Table 2) 28,135. The
steps are: (1) infusion of exactly 2.5 ml in the catheter, (2) waiting a fixed dwell time to
allow for (partial) equilibration with surrounding luminal PCO2 (in most studies 30 min),
(3) withdrawing and discarding the first 1.0 ml representing catheter dead space, (4)
aspiration of the final 1.5 ml in a syringe, capping and storage on ice, (5) sending the
capped syringe to the laboratory for analysis in the blood-gas analyzer without delay,
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and (6) calculation of steady-state PCO2 using a correction factor for each dwell time
that is less than needed for full equilibration (figure 2). With the help of the PCO2, the
arterial blood bicarbonate content and the Henderson-Hasselbalch equation, a regional,
mucosal pH (pHi) can be calculated. It is likely that the sources of error involved in
manual fluid tonometry have limited its wide scale clinical application 28,46.
Table 2. Sources of error associated with manual fluid tonometry.
Problem Result Solution
Blood-gas analyzer bias Error, dependent on fluid
and analyzer
Evaluate and correct
Measurement error in vitro 3%, in vivo 6-8% -
Poor anaerobic technique Decrease in PCO2 of 8% Careful anaerobic
technique
Improper storage of syringe Decrease in PCO2 after 60
min of at least 8%
No delay before analysis
Imprecise dwell time Error Instructions and training,
or dwell times >60 min
Dead space contamination Error of 6-10 % at 10 or 20
min dwell times
Rinse tonometer 4 times
prior to fluid installation
Incorrect correction factors Error Use correct correction
factors
Figure 2. Manual saline tonometry: the correction factor is obtained for use in calcula-
ting steady state PCO2 from measured PCO2 when a dwell time is used which is less than
that needed for full equilibration. Gastric- and sigmoid-type tonometers are shown.
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Catheter dead space
With each tonometer measurement, the balloon fluid is aspirated and measured in a
blood-gas analyzer. However, as the volume of tonometer tube itself is approximately
1.0 ml, the last 1 ml from the balloon resides in this dead space. With a new
measurement, this 1.0 ml dead space volume is then pushed into the balloon and mixed
with freshly infused fluid. Thus the PCO2 in the balloon at the start of the dwell time is
variable and depends partly on the last measured PCO2. We found that with dwell times
of 10 and 20 min, this phenomenon may cause errors in measured PCO2 of 10% and
6%, respectively, at a dead space PCO2 of 4.0 kPa. At longer dwell times this error
becomes negligible 124. The dead space error can be avoided either by calculation based
on the last measured PCO2 and the dwell time or by flushing the tonometer four times
with fresh saline in order to remove all remaining carbon dioxide containing saline in
the catheter dead space, thus ensuring a stable PCO2 of 0 kPa in the tonometer balloon
before each subsequent measurement 124. Errors associated with an unrecognized dead
space effect may have influenced the manufacturer's correction factors for short dwell
times.
Blood gas analyzer bias and dwell time-dependent correction factors
It has become apparent that blood-gas analysers, calibrated for blood or calibration
fluid, may underestimate the PCO2 measured in saline (or air) by 5-50% 72,80,82,114,129. The
magnitude of the error depends on the fluid and blood-gas analyzer used, and
potentially on the absolute PCO2 72,82,114,129. The mean error among analyzers (at PCO2
40 torr) is 12%, ranging from 5 to 29% (Table 3). Consequently, other fluids have been
evaluated and used, including succinylated gelatine 8,82,114, albumin 72, Hartmann's
solution 114, phosphate-bicarbonate 82, and phosphate or citrate buffer 3,72,82,128,129.
Buffered solutions, including succinylated gelatine may have the advantage over non-
buffered solutions that the conversion of carbon dioxide to bicarbonate in the buffer
decreases the propensity for accidental losses to the environment, either via
incompletely aerobic techniques or during processing in the blood-gas analyzer 114.
Their use may thus result in less bias and greater precision and reproducibility than for
PCO2 measurement in non-buffered solutions 72,82,129. Indeed, the error in PCO2
measurements in saline and phosphate was approximately 7% after careless syringe
handling or after 1 h storage of capped syringes 82. Measurement bias and handling
errors could be reduced to approximately 3 with the use of succinylated gelatine and
phosphate-bicarbonate buffer 82. However, buffered solutions increase the time needed
for PCO2 to equilibrate by a factor 2-5 82,129. Non-bicarbonate-based buffered solutions
could share some of the advantages without these disadvantages. Indeed, saline and
phosphate had similar PCO2 build up kinetics and similar propensity for accidental
errors, while the bias for phosphate was smaller 72,82,129. Nevertheless, saline and phos-
phate may be equally suitable as tonometer fluid, provided strict anaerobic techniques
are used and the blood-gas analyzer bias is known and taken into account 72,82.
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Table 3. Blood gas analyzer bias for PCO2 measurements in saline.
Manufacturer First author and source Bias
Radiometer
ABL2 Knichwitz, Anaesthesia 1995 -10
ABL3 Temmesfeld, Intensive Care Medicine 1997 -12
ABL130 Knichwitz, Anaesthesia 1995 -12
ABL300 Riddington, Critical Care Medicine 1994 -18
ABL330 Temmesfeld, Intensive Care Medicine 1997 -7
ABL505 Knichwitz, Anaesthesia 1995 -6
ABL520 Takala, Critical Care Medicine 1994 -6
ABL620 Venkatesh, Anaesthesia and Intensive Care 1998 -20
Ciba-Corning
Ciba238 Takala, Critical Care Medicine 1994 -5
Ciba278 Kolkman, Intensive Care Medicine 1997 -15
Ciba288 Knichwitz, Anaesthesia 1995 -29
Ciba840 Kolkman, Intensive Care Medicine1997 -11
Instrumentation Laboratories
IL1302 Takala, Critical Care Medicine 1994 -8
Novastat
Nova4 Takala, Critical Care Medicine 1994 -26
Nova5 Temmesfeld, Intensive Care Medicine 1997 -46
Nova7 Riddington, Critical Care Medicine 1994 -49
Nova9 Knichwitz, Anaesthesia 1995 -57
Eschweiler Knichwitz, Anaesthesia 1995 -51
Bias = percentage difference from true PCO2 at a PCO2 of approximately 5.3 kPa.
It is hard to asses the value of the manufacturer's correction factors as in vitro studies
from which they have been derived have not been published and the role of the dead
space effect and blood-gas analyzer bias has not taken into account 37. Blood-gas
analyzer bias has evoked debates in literature on the issue whether a correction for the
bias should be superimposed on correction for incomplete equilibration via the
manufacturer-provided correction factors 37,74,113. Compared with the manufacturer's
correction factors, the correction factors for short dwell times were considerably larger
because we avoided the dead space effect by repeated flushing of the tonometer 80.
However, the difference at long dwell times can not be explained by these effects and
must be attributed to blood-gas analyzer bias incorporated in the manufacturer's
correction factors 74,80. Indeed, the manufacturer's correction factors for dwell times
beyond 90 min are large. But we have shown that after 120 min dwell time, the
tonometer PCO2 is 96% of the surrounding value (figure 2) with a corresponding
correction factor of 1.03 compared to 1.17 advised by the manufacturer 80. That this
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1.17 does not relate to incomplete diffusion can be appreciated from a study by
Fiddian-Green and colleagues documenting the same PCO2 after dwell times of 60 and
360 min 37. In fact, correction for both incomplete equilibration using the factors
supplied by the manufacturer and blood-gas analyzer bias may result in overestimations
of PCO2 while incomplete correction may result in underestimations 56,63,80.
In vitro corrections factors have been assumed to apply to the in vivo situation 27.
However, in comparing PCO2 equilibration kinetics of tonometers placed in a saline
bath and in the stomach of healthy volunteers, the rate of PCO2 equilibration in the
latter proved 31 % slower 80. This may relate to gastric juice, gastric folds and mucus
covering the tonometer balloon in vivo. Finally, the rate of PCO2 build-up depends on
the size and diameter of the catheter, because of the sink effect of the dead space 124.
Hence, equilibration may be a few percent slower when using a long, sigmoid-type
catheter instead of the shorter gastric type. This is relevant at 10 min dwell times
only 124. When the sources of error are taken into account, manual measurements are
not only reproducible but also accurate 80. The response of the fluid technique,
however, remains relatively slow.
Temperature corrections
As with blood PCO2 and acid-base balance, it is unclear whether tonometer fluid PCO2
and pHi should be corrected for body temperature if it is not 37C, for example during
hypothermia or fever, as the correction on the blood gas machine may yield
unpredictable results 8,29,63. Nevertheless, it seems prudent to calculate the PCO2 blood-
tonometer fluid gradient from measurements made at the same temperature.
Air and others types of tonometry
From animal and human (post-cardiac surgery) studies, it has been suggested that PCO2
determination in gastric air or juice would represent mucosal PCO2 and could replace
the balloon tonometry technique 118. The balloon technique facilitates and standardizes
gastric sampling, and air as opposed to saline tonometry allows more rapid diffusion
and thus a shorter response time 129.
The recently introduced semi-continuous automated air tonometry involves a pump
which automatically inflates (and deflates) via an airtight circuit, 6-8 ml of air into the
tonometer balloon every 5-60 min (standard 10 min). This measures PCO2 in the aspira-
ted air using a modified infrared capnograph and may eliminate some of the sources of
measurement error of the manual fluid tonometry, thereby increasing the clinical appli-
cability of the technique 8,27,58,63,81,127,129. The device is commercially available (Tonocap,
Datex, Finland). The response time of the Tonocap, defined as the time needed to
reach a 95% change in PCO2 at dwell times of 5-10 min dwell times, was 10 to 18 min.
Bias was +1 to -3% and precision about 1% 27,58,81,129. The relatively long response time,
particularly at a high PCO2 and in comparison with the dwell time, may relate to a dead
space effect. PCO2 measurements by the air tonometry technique may underestimate
(high) saline tonometric PCO2, even if they are highly correlated 27,58,63,80,118. This may
relate to "overcorrection" of the latter. Air tonometry may also overestimate saline
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tonometry, possibly as a consequence of wrong correction factors for the saline
technique 8,27. The techniques may have some methodological problems and sources of
error in common. This may relate, in part, to the probable need for fasting and gastric
acid secretion inhibition and the value of the pHi versus the tonometer-blood PCO2
gradient. The accuracy of PCO2 measured by air tonometry is not influenced by
temperature corrections 8.
Capnometric recirculating gas tonometry involves a tonometer with two lumina,
connected to a circulation pump and an infrared sensor, yielding PCO2 measurements
which correlate highly with those obtained by the manual saline technique 50,51,52. Com-
pared with the latter, recirculating gas tonometry has a more rapid response time (5
min), allows on line measurements and is more sensitive during haemorrhage and
endotoxaemia 50,51,52. A new method involves a fiberoptic PCO2 sensor which allows
monitoring of pH and PO2 73. The sensor proved faster and more accurate than saline
tonometry, both in vitro and in vivo. The potential for using this probe nasogastrically
needs further study. Other techniques that may become available for direct mucosal
PCO2 measurements include the ion sensitive field effect transistor sensor 101,104,119,126.
Finally, tonometry can also be used to measure gastrointestinal luminal nitric oxide
concentrations 1.
CLINICAL APPLICATIONS
Diagnostic aid in symptomatic celiac and mesenteric vascular disease
Some patients with otherwise unexplained abdominal signs of dyspepsia and pain
(abdominal angina) may have chronic gastrointestinal vascular disease, but it is hard to
establish a relation between signs and symptoms on the one hand and objective
indicators of gastrointestinal hypoperfusion, such as abnormal angiographic findings,
on the other 81. The management of these patients and the effect of reconstructive
vascular surgery may be hard to predict. A diagnostic test for gastrointestinal
hypoperfusion, that also predicts the success of surgery is therefore needed 81,85. It has
been suggested that gastric tonometry during a test meal may be used 16,39. However,
feeding may confound tonometry in the stomach and may thereby yield negative
results, even in patients with otherwise proven splanchnic hypoperfusion 43,77.
Alternatively, during exercise, the perfusion of the splanchnic organs is at risk because
of the "steal" effect of the increased blood flow to skeletal muscle. Hence, vascular
disease in the splanchnic region and diminished vasodilator reserve could increase the
risk for hypoperfusion during exercise. Indeed, many patients with presumed
gastrointestinal vascular disease may have abdominal complaints on exercise. We
therefore assessed the value of gastric exercise tonometry in managing patients with
suspected gastrointestinal hypoperfusion. When the patients were divided on the basis
of normal angiograms and those with stenotic lesions in the celiac or superior
mesenteric artery, the PCO2 gradient during exercise did not increase in the former but
increased to about 2.7 kPa in the latter group, with only a minority of patients
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exhibiting a supranormal gradient at rest. Furthermore, the exercise tonometric findings
correlated with a symptom score, the extent of angiographic abnormalities and the
presence of discrete mucosal lesions on gastroscopy, consistent with mucosal
hypoperfusion and damage. In some patients re-examined after reconstructive surgery,
the exercise tonometry test had normalized 78. Gastric tonometry could help to
diagnose acute mesenteric vascular disease resulting in bowel hypoperfusion and
necrosis, provided that the stomach is also partly involved and some metabolism
remains 10,73,118.
Estimating prognosis from pHi or the PCO2 gradient and pHi in critically ill
patients
The conditions wherein (gastric) tonometric variables proved prognostically significant
for the development of multiple organ failure and subsequent death are: orthotopic
liver transplantation 136; acute pancreatitis 17; cardiopulmonary bypass and other types
of major, emergency vascular surgery 29,30,41,49,54,95,115; sepsis; trauma 25,26,49,62,65,68,84; and
mechanical ventilation 31,59,94,97. Furthermore, an elevated PCO2 gradient and a low pHi
were predictive of failure to wean mechanically ventilated patients, independently of
arterial blood and ventilatory variables, presumably because of splanchnic diversion of
blood flow to exercising respiratory muscles with an increased workload 18,31,97.
The fact that tonometric PCO2 depends partly on arterial PCO2, and that the bicarbonate
content is shared between arterial pH and calculated pHi, may explain the correlation
observed between arterial pH and pHi, and the approximate similar predictive value of
both indices 19,23,41,45. Although splanchnic hypoperfusion and lactate production may
influence the systemic indicators, tonometric variables may nevertheless correlate only
poorly with systemic factors 40,48. As hyperlactataemia-associated metabolic acidosis is
prognostically unfavourable in critically ill patients, it can be questioned if tonometry is
of additive predictive value 4,19,48,59,62,65,84. A low (subnormal) pHi or elevated PCO2
gradient may be superior or have additive value in the prediction of morbidity, that is
multiple organ failure and mortality, to global haemodynamic and metabolic variables,
including the lactate concentration and acid-base variables in the systemic blood of
critically ill patients 25,26,32,40,42,56,59,62,68,84,94 ,95,97,99. A subnormal gastric pHi may predict
circulating markers of an inflammatory response and a poor outcome with
postoperative complications and multiple organ failure, after major cardiac, vascular
and abdominal surgery 30,99. After cardiopulmonary bypass surgery, however, neither
the pHi nor the PCO2 gradient in the stomach may constitute an early predictor of
increased permeability, endotoxaemia and death in the ICU, whereas global haemo-
dynamics and the systemic lactate level may predict a downhill disease course 6,14,54,115.
Even though the PCO2 or pH gradients may be more specific indicators of gastric hypo-
perfusion than the pHi, it may be questioned if the former are equally useful prognostic
parameters as the pHi, which incorporates a systemic variable 25,26,40,42,45,59,62,68,94. In
recent studies in critically ill patients pHi, but not pH or PCO2 gradients, proved
prognostic indicators 45,59, suggesting an additive value of systemic acid-base disorders
in predicting outcome. In addition, a low pHi may predict occurrence of stress ulcer
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bleeding and ischaemic colitis, when measured in the stomach and sigmoid colon of
critically ill patients 12,37,71,123,131. Hence pHi may be superior to the PCO2 gradient in
predicting stress ulcer (bleeding) in the stomach, since the development of stress ulcers
may not only relate to local factors but also to systemic acidosis 69. In fact, lowering of
the blood bicarbonate content is a risk factor and systemic alkalinization protects
against stress ulcer development during haemorrhagic shock and mucosal
hypoperfusion in animals 69. Taken together, it emerges that the components of pHi,
PCO2 as measure of alveolar ventilation and gastric hypoperfusion, and bicarbonate
concentration as measure of general circulation status, are of varying importance in
different patients and disease stages.
Children
In a study in paediatric patients with sepsis, lactate content, but not pHi or PCO2
gradients, predicted outcome, suggesting superiority of systemic over regional
abnormalities 32. In contrast, in many other studies on critically ill (septic) children, pHi
and PCO2 (or pH) gradient were better predictors than systemic haemodynamic and
metabolic variables, including the blood pH, bicarbonate and lactate concentrations, for
haemodynamic complications, multiple organ failure and survival 23,24,31,32,56,84.
Sigmoid colon
Even though the appropriate methodology of sigmoid tonometry has still to be
established, studies have suggested that the technique may be helpful in predicting
tissue hypoxia and injury leading to ischaemic colitis, the main cause of morbidity and
mortality after major abdominal vascular surgery 12,37,71,123,131. Colonic hypoperfusion
detected by tonometry may be associated with endotoxaemia and cytokine release that
might contribute to mortality 123. Gastric tonometry may also be of predictive value
after (emergency) major vascular surgery 12,89,95.
Effect of interventions
As a low gastric pHi or elevated PCO2 gradient may be prognostically important, studies
have examined the effect of various interventions on the tonometric variables, but the
beneficial effect on morbidity and mortality of "pHi guided" treatment is still
controversial 7,49,105,109. A variety of treatment procedures consisting of fluid and drug
therapy, such as dopamine, dopexamine, epinephrine and norepinephrine, aimed at
restoration of splanchnic blood flow, have been evaluated after cardiopulmonary
bypass surgery 11,42,100,111,112,130, trauma and sepsis 15,48,49,68,87,88,102,103,122,128. Colloid fluids
may be superior to crystalloids but different types may differ in their capability to
increase global oxygen delivery and uptake, and to ameliorate a low gastric pHi, in
septic and postoperative patients 15,92. Some catecholamine treatments in
haemodynamically compromised patients may benefit the splanchnic circulation and
others may not, as judged from a fall in the gastric PCO2, an increase in pHi, or both, in
a variety of conditions 7,11,42,48,87,88,92,103,108,111,122,128,130. For example, norepinephrine and
dobutamine decreased the (elevated) gastric PCO2 gradient and increased the
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(subnormal) pHi. Dopamine, dopexamine, or epinephrine treatment had no effect or
tended to further decrease the pHi in the treatment of sepsis and shock, even if
systemic haemodynamics were unchanged or improved 48,87,88,92,103,128. Dopexamine or
dobutamine treatment may not prevent a decrease in pHi during and after
cardiopulmonary bypass surgery, even if they increase systemic and hepatosplanchnic
blood flow and oxygen delivery 11,42,111,130. In other critically ill patients, dopexamine
appeared to improve splanchnic blood flow and a subnormal pHi, independently of
systemic haemodynamics, suggesting selective splanchnic vasodilation, while dopamine
had no such effect 122.
Vasodilator therapy by infusion or inhalation of prostacyclin may improve
hepatosplanchnic blood flow and decrease the tonometric gastric PCO2 gradient during
septic shock 34. Administration of nitroprusside or angiotensin converting enzyme
(ACE) inhibitors did not change the gastric PCO2 gradient or pHi after cardiac surgery
and this argues against a role for angiotensin in splanchnic vasoconstriction 110,112. ACE
inhibition may ameliorate an increased PCO2 gradient and a low pHi in trauma, even if
systemic haemodynamic variables do not change 67. Pulsatile blood flow may better
preserve gastric mucosal perfusion adequacy than non-pulsatile flow during
cardiopulmonary bypass 41. Inducing muscular paralysis in mechanically ventilated
patients may increase a reduced pHi, suggesting redistribution of blood flow from
respiratory to splanchnic organs 90. Treatment of sepsis and trauma patients with
antioxidants may prevent a decrease in oxygen extraction abilities, and gastric pHi,
particularly during transient hyperoxia 7. During large intestinal surgery, gastric PCO2
increased relative to blood values, independent of unchanged global haemodynamics;
adjunctive clonidine administration did not attenuate this increase 134. Abdominal
decompression in trauma-related intra-abdominal hypertension may normalize a low
pHi, particularly in patients who survive 61.
CONCLUSION
Gastrointestinal tonometry of the luminal to blood PCO2 gradient can be used to assess
adequacy of mucosal perfusion provided that, if applied to the empty stomach, acid
buffering and carbon dioxide generation are avoided. Appropriate use may improve the
accuracy of manual fluid tonometry until the semi-continuous automated air tonometry
technique, which may eliminate some sources of error inherent to the manual
technique, becomes widely available. This may broaden the clinical applicability of
gastrointestinal luminal tonometry as a monitoring tool in a variety of conditions.
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ABSTRACT
Heavy physical exercise may cause gastrointestinal signs and symptoms, and even
though splanchnic blood flow may decrease through redistribution by more than 50 %,
it is unclear whether these signs and symptoms relate to gastrointestinal ischemia. In ten
healthy volunteers, we studied the effect of exercise on gastric mucosal perfusion
adequacy using air tonometry. Two relatively short (10-min.) exercise stages were
conducted on a cycle ergometer, aiming for 80% of maximum heart rate and 100% of
maximum heart rate, respectively. The gastric intragastric-arterial PCO2 gradient
(PCO2) was elevated (by 1.1 ± 1.0 kPa) over baseline values (-0.1 ± 0.3 kPa) only after
maximal exercise (p<0.001). The PCO2 positively correlated with the arterial lactate
level, taken as an index of exercise intensity (Spearman’s rank test: r=0.76, p<0.0001).
By bilinear regression analysis, a lactate level of 12 mmol/l above which a sharp rise in
the PCO2 occurred, was calculated. We conclude that in healthy volunteers with
normal splanchnic vasculature, gastric ischemia may develop during maximal exercise,
as judged from intragastric PCO2 tonometry.
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INTRODUCTION
During heavy physical exercise, up to 80 per cent of the increase in cardiac output may
be directed to the working muscles to match the increased metabolic demands, thereby
curtailing blood flow to splanchnic organs 43. Using Doppler-ultrasonography, a
decrease in splanchnic blood flow of up to 50% has been observed following physical
exercise 32,34. The consequences of such a decrease in blood flow are unclear, but may
lead to gut mucosal ischemia, as observed in animal models of shock 15.
It is well established that strenuous exercise may lead to gastrointestinal abnormalities
and cause symptoms such as abdominal pain or discomfort, nausea, vomiting, and
diarrhoea. Numerous studies have focused on gastrointestinal disorders during exercise
2,21,24,25,28,29,33,35,41. The majority of these studies addressed the subject of gastrointestinal
motility but few have investigated the possible role of ischemia as underlying cause
3,8,12,22,36,38,42. This may be partly explained by the lack of an accurate test to assess actual
ischemia, independent of metabolic rate and absolute perfusion.
Changes in perfusion per se do not necessarily indicate changes in oxygen supply to
demand balance, when demand decreases as a consequence of fasting, for instance. The
intragastric luminal PCO2 as measured by tonometry, however, is considered to reflect
the mucosal oxygen supply to demand balance 18, so that hypoperfusion increases the
intragastric-arterial PCO2 gradient (PCO2), following a decreased washout and
increased production of CO2 in ischemic tissue, by liberation of CO2 from HCO3-
buffering of anaerobically produced metabolic acids 10. In fact, heavy exercise may
result in an increase of PCO2 31. The latter study, however, does not give insight into
the level of exercise inducing gastric mucosal ischemia. This is of importance since
exercise tonometry has been suggested in a previous paper by the authors to be a non-
invasive diagnostic tool for stenotic splanchnic vascular disease 17, but the specificity of
abnormal exercise tonometry for vascular disease should be confirmed by normal
tonometric values at a similar level of exercise in healthy volunteers with normal
splanchnic blood vessels. The cited study was done with help of the slow manual saline
tonometry system, while the introduction of air tonometry thereafter has allowed for
more rapid and accurate intragastric PCO2 tonometry 20.
In consideration of above data, we hypothesised that maximal rather than submaximal
exercise in healthy volunteers with normal splanchnic blood vessels causes gastric
mucosal ischemia as judged from intragastric air PCO2 tonometry.
MATERIALS AND METHODS
Subjects
Ten healthy untrained and non-smoking volunteers (5 males and 5 females, mean age
25.4 range 23-28 years), taking no medication other than oral contraceptives, were
included in the study. All subjects were informed about the nature, purpose and
possible risks involved in the study before giving their consent. The study was
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performed according to the ethical guidelines of our institution after approval of the
Institutional Ethics Committee.
Duplex sonography
To exclude splanchnic arterial abnormalities, all subjects underwent Duplex sonography
of the splanchnic vessels. In the week prior to the exercise studies, following an
overnight fast, Duplex sonography was performed by an experienced investigator
(B.H.G.) using a Diasonics VST-master ultrasonography device. After identifying the
vessels and confirming patency and antegrade flow, the peak-systolic and end-diastolic
flow velocities during in- and expiration were measured in the celiac (CA) and superior
mesenteric (SMA) arteries and the aorta. Peak-systolic flow velocities below 200 and
275 cm/sec and end-diastolic flow velocities below 55 and 45 cm/sec were regarded as
normal for the CA and SMA, respectively 26,30.
Tonometry
The subjects were studied in the afternoon, after a fasting episode of at least four hours
following a light breakfast. One week prior to tonometry exercise testing, the maximum
workload and heart rate (HRmax) were determined utilizing an incremental exercise
protocol (cycle ergometry, work rate increment 25Watt/min) until exhaustion 11. A
standard balloon-tipped tonometry catheter (Trip sigmoid catheter, Tonometrics,
Helsinki, Finland) was inserted nasogastrically and placed at 55 cm from the tip of the
nose. The catheter was attached to an automated air tonometry device (Tonocap,
Datex-Engstrom, Finland) which uses a pump to automatically inflate and deflate the
tonometer balloon via an airtight circuit, and analyzes PCO2 of the aspirated gas by
infrared capnography. The tonometry device was set up to measure intragastric PCO2
(PgCO2) every ten minutes. To prevent CO2 production by buffering of gastric acid,
100 mg of ranitidine was administered intravenously one hour prior to the baseline
tonometry measurements (t=-60 min) and again immediately after the first exercise
episode (t=30 min). This dose of ranitidine sufficiently suppresses gastric acid
production within one hour 19,39.
A radial artery catheter was inserted in the non-dominant arm to allow blood sampling.
Exercise testing
We applied two exercise periods (EX1 and EX2), ten minutes of duration each, with 60
minutes of rest between the two periods. The two exercise periods were aimed to result
in steady state exercise at a submaximal (80% of HRmax) and maximal work rate level
(100% of HRmax), respectively. To achieve this, the workload was gradually increased
during the first 5-min of EX1 and 7-8 min of EX2, and remained constant thereafter.
Exercise was performed on an electromagnetically braked bicycle ergometer (Lode,
Groningen, Netherlands). During the exercise stages a 12-lead electrocardiogram was
recorded (Case 12, Marquette Electronics Inc., Milwaukee, USA) and in all but one
subject breath-by-breath oxygen uptake (VO2), and respiratory gas exchange ratio (RQ)
Gastric ischemia in healthy volunteers 45
were measured by a respiratory gas analyzer system (Oxycon-Jaeger, Bunnik, the
Netherlands).
Figure 1. Schematic time frame of the exercise tonometry study.
Protocol
In figure 1 the time frame of the study protocol is schematically displayed. Baseline
measurements of blood and tonometric variables were done at t=10 and t=20 min.
(BL1). The submaximal exercise period (EX1) was from t=20 to 30, with measure-
ments at t=30 min. Recovery measurements (RC1) were done at t=40 min. After a
wash-out period, the second baseline period measurements were done and at t=70 and
t=80 (BL2), followed by the maximal exercise period (EX2) from t=80 to 90, with
measurements at t=90 min. A second recovery measurement (RC2) was done at t=100
min. During exercise, the heart rate (HR) was recorded and the percentage of HRmax
was calculated every 30 seconds. VO2 and RQ were averaged and stored every 30 sec
during the exercise periods. VO2 is expressed as percentage of predicted maximum VO2
(VO2max). Predicted VO2max was calculated using equations by Wasserman 44. At t=10,
t=20, t=30, t=40, t=70, t=80, t=90, and t=100 min, arterial blood samples were drawn
for determination of arterial PCO2 (PaCO2), base excess, and bicarbonate (blood gas
analyzer; Radiometer ABL520, Copenhagen, Denmark), and lactate (enzymatic assay;
Cobas Fara, Roche Diagnostics, Branchburg, USA). Every ten minutes the Tonocap®
measured PgCO2. The gastric-arterial PCO2 gradient (PCO2 = PgCO2 – PaCO2) was
calculated.
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Statistics
Values are given as mean ± SD unless otherwise stated. For all baseline values the mean
of the two consecutive measurements was taken. Differences between study periods for
any given parameter were tested by one way analysis of variance (ANOVA) for
repeated measurements, followed by a Tukey-Kramer multiple comparison test. For the
pooled results of both exercise periods, the relation between maximal lactate levels and
PCO2 was calculated using Spearman’s rank correlation coefficient. Bilinear regression
analysis was done to evaluate a lactate level threshold for PgCO2 rises 7. A p-value
< 0.05 was considered statistically significant.
RESULTS
Duplex sonography
All subjects had normal patent CA and SMA with antegrade flow in both vessels. Due
to intestinal gas, reliable flow measurements were not possible in the CA in one subject
and in both vessels in another subject. All others had normal flow velocities.
Exercise tonometry
Cardiopulmonary measurements. There were no differences in HR, VO2 , and RQ between
the two baseline episodes (Table 1). At the end of both exercise stages all
cardiopulmonary parameters differed from baseline. HR increased from 78 ± 14 at
baseline to 162 ± 6 beats/min (83 ± 3 % of HRmax) after EX1 (p<0.0001) and to
189 ± 8 beats/min (97 ± 4 % of HRmax) after EX2 (p<0.0001). The VO2 rose to
91 ± 23 % of predicted VO2max at the end of EX1 and to 130 ± 20 % of predicted
VO2max at the end of EX2 (p<0.0001 for both vs. baseline).
Table 1. The study parameters at different baseline, exercise and recovery periods.
BL1 EX1 RC1 BL2 EX2 RC2
HR (/min) 78±14 162±6** 83±12 189±8** ††
% of HRmax 83±3 97±4
††
VO2 (l/min) 0.43±0.17 2.12±0.64** 0.43±0.18 3.04±0.75** ††
RQ 0.72±0.04 0.99±0.07** 0.72±0.06 1.11±0.08** ††
PaCO2 (kPa) 5.1±0.7 5.0±0.5 4.9±0.4 5.0±0.6** 4.4±0.7** † 4.3±0.5**
HCO3
- (mmol/l) 23.9±2.2 19.1±1.6** 20.4±1.3** 23.7±1.9 14.2±2.5** † 14.9±2.9**
BE (mmol/l) -0.3±1.6 -6.0±1.8** -3.8±1.6** -0.1±1.5 -11.8±3.0** † -10.5±3.9**
lactate (mmol/l) 0.5±0.1 6.5±2.4** 3.3±1.6** 0.7±0.2 12.8±3.2** † 8.7±3.2**
PgCO2 (kPa) 4.9±0.6 5.3±0.6* 4.9±0.5 4.9±0.6 5.5±0.6** 5.0±0.4
Values in mean ± SD; for abbreviations see text
* p< 0.05 for value vs. baseline value, ** p< 0.001 for value vs. baseline value,
† p<0.001 for value comparing EX1 vs. EX2, †† p<0.0005 for comparing EX1 vs. EX2
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Blood parameters. There were no differences between the two baseline episodes. PaCO2
did not change after EX1 but decreased after EX2 and remained below baseline in
RC2. The lactate increased and the bicarbonate and BE levels decreased during both
exercise periods, but more during EX2 than EX1.
Tonometry parameters. The baseline PgCO2 did not differ between both baseline periods.
During EX1, PgCO2 increased, whereas the PCO2 did not change significantly (figure
2). During EX2, PgCO2 and PCO2 increased. During RC2 PgCO2 returned to baseline
but PCO2 remained elevated over baseline. The mean PgCO2 in both baseline periods
was 4.9 ± 0.2 kPa, the coefficient of variation 4.3%. The PCO2 during both baseline
periods was –0.2 ± 0.4 kPa, with an upper limit of normal (mean + 2 SD) 0.6 kPa.
Tonometry variables vs. exercise level. A positive correlation was observed between both
PgCO2 and PCO2 with exercise level, as indicated by serum lactate at the end of the
exercise stage (r = 0.50, p<0.05 and r = 0.76, p<0.0001). No increase ofPCO2 over
the normal upper threshold of 0.8 kPa was seen during exercise with lactate levels
below 8 mmol/l, while in 5 out of 6 tests resulting lactate levels above 14 mmol/l the
PCO2 exceeded this threshold 19. In figure 3 the relationship between serum lactate
level at the end of the exercise stage and PCO2 is shown. Using bilinear regression
analysis, a lactate threshold value of 12 mmol/l was calculated above which PCO2
started to rise (r2 = 0.73).
Figure 2.PCO2 in the different test episodes. Values are means ± SD.
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Figure 3. Gastric-blood PCO2 gradient vs. lactate level after 10 min. exercise
DISCUSSION
The results of the present study show that in subjects with normal splanchnic
vasculature, gastric ischemia can develop after only 10 minutes of maximum physical
exercise. The development of gastric ischemia strongly depended upon the exercise
intensity. Furthermore, our study demonstrates that air tonometry can be used for
assessment of the adequacy of gastric mucosal perfusion during physical exercise.
The bilinear pattern of the gastric-blood PCO2 gradient during exercise, with a marked
increase above a threshold exercise intensity, is in agreement with studies indicating that
tonometric measurement of gastric intramucosal PCO2 is a reliable index of the
adequacy of splanchnic mucosal perfusion 16,18. If tonometry results depend on blood
flow only, a linear pattern between PCO2 gradient and lactate should have been obser-
ved 13. In contrast, it was previously shown in animal models that a small reduction in
gastrointestinal blood flow did not influence the PgCO2, but when the blood flow fell to
less than 50% of baseline, hypoperfusion caused an increased PgCO2 in parallel with a
fall in tissue O2 tension and consumption 15,40. Indeed, the gastric-blood PCO2 gradient
may be the most sensitive and specific tonometric parameter of gastrointestinal
perfusion, independent of systemic metabolic and respiratory changes 18.
The increase inPCO2 during maximal exercise is partly caused by a decrease in PaCO2.
The latter is the result of increased alveolar ventilation in response to metabolic acidosis
due to anaerobic muscular metabolism 11. However, in mechanically ventilated patients
is has been shown that changes in PaCO2 are closely and swiftly followed by changes in
PgCO2, thereby not influencingPCO2 23. But, even if neglecting the decrease in PaCO2,
the relationship between the increase in PgCO2 during exercise and arterial lactate level
shows a similar bilinear pattern as PCO2 vs. lactate level: no increase of PgCO2 up to a
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threshold lactate level of 12 mmol/l and an increase above this lactate threshold
(r2 = 0.36).
Our present study confirms the findings of the study of Nielsen et al. which showed
that gastric ischemia occurred during heavy exercise in trained rowers at exercise levels
close to their maximum aerobic capacity 31. Using fluid tonometry they observed,
similar to our present study, a gradual increase in PgCO2 during exercise with a
concomitant decrease in PaCO2. A direct comparison of both studies is difficult since
the Nielsen study reported on the previously advocated but now largely abandoned
pHi, a calculated value incorporating arterial bicarbonate levels as well. With profound
metabolic acidosis, the pHi might be a poorer predictor of mucosal ischemia than
PCO2. Another potential confounding factor might have been insufficient acid
suppression, as one of their baseline PgCO2 already measured up to 8.5 kPa. Similar to
previous studies by our group, we used high dose intravenous ranitidine to ensure
adequate acid suppression in our subjects 19.
Automated air tonometry offers several advantages over manual fluid tonometry,
including superior accuracy, speed and reproducibility 18. It is less laborious and
involves less error-prone steps, and the faster diffusion of CO2 in air results in shorter
equilibration times. In our study, air tonometry may have slightly underestimated PgCO2
values, leading to negative PCO2 baseline values in the majority of measurements (28
of 40 baseline measurements). In one subject in our study, all PgCO2 values were lower
than arterial PCO2 values, resulting in negative gradients, even at maximal exercise. The
most likely explanation is the occurrence of air swallowing causing dilution of
intragastric gas.
The PCO2 threshold for anaerobic metabolism is still unclear 18. The range of normal
PgCO2 andPCO2 in our study is in close agreement with the study by Creteur et al. on
air tonometry showing a normal upper limit of normal of 0.8 kPa for the gradient 4.
Schlichtig et al. demonstrated that a fall in tissue O2 tension and consumption,
development of anaerobic metabolism and production of lactic acid, occurred at a
PCO2 of 3.5 kPa or greater, a value that can be regarded as the critical gradient 40.
Thus, it may be questioned whether the increased PCO2 as shown in this study indeed
indicate ischemia rather then hypoperfusion of the gastric mucosa. Nevertheless, we
cannot exclude ischemia and anaerobic metabolism in the gastric mucosa even at
gradients lower than the critical values reported by Schlichtig et al. The 10-minute
measurement interval of air tonometry may have resulted in an underestimation of the
actual peak PgCO2 during exercise periods of 10 min. Indeed, the first minutes of the
exercise periods were used to gradually increase the workload. Therefore, anaerobic
CO2 production could have occurred only in the last minutes of the exercise episode,
not lasting long enough for full PCO2 equilibration in the tonometry balloon and
resulting in a measured intragastric PCO2 underestimating the actual intraluminal PCO2
at the end of the exercise. Moreover, exercise-induced hypoperfusion might result in
patchy ischemia with anaerobic areas surrounded by still well perfused areas, similar to
the ischemic pattern demonstrated in hypovolemic shock 6,27.
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An alternative explanation for increasing PCO2 after strenuous exercise, other than
splanchnic vasoconstriction and ischemia, could be an increase in intraabdominal
pressure, leading to increased wall tension in the digestive tract and even reduced
mucosal flow and ischemia. Indeed, in pigs it was demonstrated that prolonged increase
in intraabdominal pressure of 1.5 to 3 kPa may decrease mucosal blood flow by
30-40% 5. Similar intraabdominal pressures have been measured during exercise 14.
However, as during exercise the intraabdominal pressure is not continuously elevated,
but changing during each respiratory cycle between approximately 0 and 3 kPa it is
unlikely that these short (1-2 seconds) periods of intraabdominal peak-pressure will lead
to mucosal ischemia. Moreover, if gastric mucosal ischemia would have been caused by
an increase in abdominal pressure during exercise, a rapid normalization in the recovery
phase would be expected. In the present study however, in the recovery phase PCO2
remained elevated in four subjects and in one subject even further increased. This result
is in agreement with the finding that during recovery after exercise the splanchnic flow
may be impaired for as much as 30 minutes 34.
An interindividual difference in the response of PCO2 to the two exercise intensities
was noted. In three subjects, the PCO2 after maximal exercise (with lactate levels
increasing to 14.3 mmol/l) was not or only slightly higher than after submaximal
exercise and still well below the normal threshold of 0.8 kPa. In contrast, in one subject
PCO2 was already elevated after submaximal exercise (lactate 8.4 mmol/l) and
increased greatly after maximal exercise (lactate 15.2 mmol/l), resulting in the highest
PCO2 of all subjects. Although splanchnic arterial abnormalities were excluded by
Duplex sonography, differences in microvascular anatomy and physiology might very
well explain this interindividual susceptibility to gastric mucosal ischemia. This might
result from differences in training status as, although none of the subjects were
competitive athletes, all were recreationally active up to different degree 9.
Our results demonstrate a threshold in exercise intensity, as judged from the arterial
lactate level, above which a marked increase inPCO2 as a reflection of gastric mucosal
ischemia. This finding of a lactate threshold in individuals with normal splanchnic
vasculature beyond which gastric ischemia may develop has important implications
when using exercise gastric tonometry as a diagnostic tool in patients suspected for
having splanchnic arterial disease. In these patients, in contrast to control patients,
exercise of even moderate intensity has shown to lead to gastric ischemia as judged
from a rise in the tonometric intragastric PCO2 17. Our current results in healthy
volunteers suggest that for optimal performance of the test in patients and in order to
prevent false positive results, it is mandatory to continuously monitor and, if necessary,
adjust the exercise intensity to keep the lactate level below 8 mmol/l.
In many studies, exercise led to a variety of gastrointestinal abnormalities. The etiology
of these abnormalities is still unclear, however. Exercise has been shown to lead to
delayed liquid gastric emptying 21,25,35, the magnitude of the delay depending on the
exercise intensity 29. Using ultrasonography it has been shown that impaired motility
may be explained by exercise-induced closure of the pylorus and a decreased gastric
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antral area 2. Exercise has also shown to affect intestinal postprandial motor activity 41.
The intestinal epithelial barrier function may be impaired since heavy exercise may
result in increased intestinal permeability and impaired water absorption 24. Apart from
these functional alterations, heavy exercise, especially marathon running, is also known
to cause gastrointestinal blood loss, gastritis, and colitis, which are –at least partially-
ascribed to gastrointestinal ischemia 3,8,12,22,36,38,42. Although often suggested as playing a
key role in the development of exercise-induced gastrointestinal abnormalities,
gastrointestinal hypoperfusion has not yet been proven to be the cause of these
exercise-induced abnormalities. Several investigations using Doppler ultrasound and
thermodilution techniques, have shown an exercise-induced decrease of splanchnic
blood flow, but failed to address the issue of metabolic demand 1,32,34,37,43. Our present
study using air tonometry shows that in subjects with normal splanchnic vasculature
gastric ischemia may indeed develop early during maximum physical exercise, and that
the development of gastric mucosal ischemia is strongly dependent upon the exercise
intensity.
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ABSTRACT
Background and aims. Gastric exercise tonometry can be used for as a functional test in
the diagnosis of gastrointestinal ischemia. To achieve maximal diagnostic accuracy the
exercise build-up should be controlled to reach submaximal exercise levels, because
maximal exercise levels can result in false-positive tests. This study evaluates three
different parameters for monitoring and adjustment of exercise levels.
Methods. From 1997 – 2000, 178 exercise tests were performed in healthy volunteers as
well as patients suspected of gastrointestinal ischemia. The parameters used were: heart
rate monitoring (HRM), RQ-monitoring (RQM) and serial rapid lactate measurements
(RLM).
Results. Exercise levels above submaximal were reached in 20% of HRM, 2% of RQM,
and 5% of RLM (p<0.05 for HR vs. RQ and lactate). Low exercise levels were seen in
5%, 10% and 41% in HRM, RQM and RLM, respectively (p<0.01 for RLM vs. HRM
and RQM). Low exercise levels did not result in an increase in false negative gastric
exercise tonometry (5% compared to 6% of all tests, n.s.), whereas high levels resulted
in 43% false-positives (compared to 19% in all tests, p<0.001).
Conclusion. Maximal exercise levels leads to increased false-positivity; lower exercise
levels did not influence tonometry accuracy. Although RQ-monitoring resulted in the
greatest proportion of optimal exercise tests, rapid serial lactate would be our method
of choice, as it combines optimal diagnostic accuracy, low-cost and simplicity and
allows for accurate gastric exercise tonometry in daily clinical practice.
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INTRODUCTION
For diagnosis in patients with suspected chronic gastrointestinal ischemia, we have
previously shown that gastric exercise tonometry can be used as a functional test
providing information about the adequacy of the gastrointestinal mucosal perfusion 3,8.
In these studies it was demonstrated that during 10 minutes of submaximal exercise
gastric ischemia occurred only in patients with splanchnic artery stenosis. An extreme
exercise level may cause false-positive tests, as was shown in a study in healthy
volunteers, where lactate levels exceeding 8 mmol/l resulted in gastric ischemia in
50% 9. Furthermore, it may be conceivable that exercise of very low intensity can lead
to false-negative results in exercise tonometry used for diagnosing chronic
gastrointestinal ischemia. In order to prevent false positive and false negative tonometry
tests, the exercise intensity should be monitored throughout the test and if necessary
adjustments of the workload should be made in order to obtain an optimal exercise
test.
Exercise intensity can be monitored by various parameters including arterial plasma
lactate concentration, decrease in serum arterial base excess or bicarbonate
concentration (which both are directly related to lactate level), heart rate, and
respiratory parameters (respiratory gas exchange ratio: RQ =VCO2/VO2) 13.
In this study we evaluated and compared three consecutive time periods in each of
which a different parameter was used for monitoring the exercise intensity and
adjusting the workload in order to obtain a submaximal exercise test. Initially heart rate
monitoring was used, in the second period exercise intensity monitoring and
adjustment was guided by monitoring of RQ. In the final period exercise intensity was
monitored by serial rapid lactate measurements.
SUBJECTS AND METHODS
In ten volunteers (5F, 5M; mean age 25, range 23-28 yr.) and 157 patients (59M, 98F;
median age 55, range 13-82 yr.) 178 tonometry exercise tests were performed. The
volunteers were tested as part of a more extensive study investigating the effect of two
different exercise levels on gastric tonometry 9. All patients were suspected for having
symptomatic chronic gastrointestinal ischemia. Their clinical presentation was that of
unexplained abdominal pain, weight loss, diarrhoea or gastric ulcers. Gastric tonometry
exercise testing was performed as a diagnostic function test in addition to duplex
sonography and selective angiography of the splanchnic vessels. A part of the patients
in this study have been previously described in a publication of our group investigating
the diagnostic potential of gastric exercise tonometry 8.
The procedure of gastric tonometry exercise testing was described in detail in a
previous study 9. In short, a standard nasogastric tonometry catheter was inserted and
connected to an automated air tonometry device that was set up to measure intragastric
PCO2 every ten minutes. All subjects were studied after a fasting episode of 4 hours.
Ranitidine 100 mg was given intravenously 90 minutes prior to exercise testing. A radial
artery catheter was introduced in the non-dominant arm to allow sequential arterial
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blood sampling. Exercise was performed on an electromagnetically braked bicycle
ergometer (Lode, Groningen, Netherlands).
Monitoring exercise intensity and adjusting the workload
The maximal workload (Wmax) was estimated by using standard criteria, using age, sex,
and weight. 1 The exercise episode was started at 10% of Wmax and in the first 4-6
minutes the workload was increased every minute with 10% of Wmax. The workload
was intended to remain constant thereafter at a submaximal exercise level. Three
different approaches for monitoring the exercise intensity and -if necessary- guiding
additional adjustments of the workload were evaluated in consecutive periods.
First period: HR-triggered tests. Exercise intensity was monitored by measuring HR,
aiming for a HR in the last 4-5 minutes of 80% of maximal predicted heart rate
(HRmaxpred). HRmaxpred was calculated by the following formula: HRmaxpred = 210 –
0.65*age 12.
Second period: RQ-triggered testing. The workload adjustments were guided by
measurement of the RQ, aiming for an RQ of 1.0 in the last 4-5 minutes of the exercise
episode. This RQ was chosen as it indicates the anaerobic threshold
Third period: lactate-triggered. In 40 of the RQ-triggered tests serial rapid lactate
measurements were done during exercise at t=0, 4, 6, 8 and 10 min. These measure-
ments were not used for guiding the exercise intensity, but to develop a lactate-based
exercise triggering protocol. From the results of rapid serial lactate measurements in the
RQ-triggered period, an algorithm was developed for triggering the exercise intensity
(see table 1). We aimed for a lactate concentration of 4 mmol/l in the last 4 minutes of
the test. In parallel with RQ-triggering at an RQ-value of 1.0, this lactate level resembles
the anaerobic threshold, at which redistribution of blood flow patterns is initiated.
Table 1. Algorithm for lactate-guide exercise intensity adjustments.
start at 10% of predicted Wmax
increase workload by 10% of Wmax every minute (at t=1, 2, 3, 4, 5, 6 min)
lactate measurements at t= 4, 6, 8 and 10 minutes
if lactate > 3 mmol/l: decrease workload by 10% of Wmax
if lactate not > 1 mmol/l: increase 2x 10% of Wmax
In the first two periods (HR- resp. RQ-triggering) the tests were performed at the
pulmonary function department of our hospital. During these exercise tests a 12-lead
electrocardiogram was recorded (Case 12, Marquette Electronics Inc., Milwaukee,
USA). Heart rate (HR) was recorded every minute. Breath-by-breath oxygen uptake
(VO2), and respiratory gas exchange ratio (RQ) were measured by a respiratory gas
analyzer system (Oxycon-Jaeger, Bunnik, the Netherlands) and recorded every 30 sec.
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In the third time frame (rapid serial lactate triggering) the test was performed at the
gastroenterology function department, HR was monitored, but respiratory parameters
were not monitored.
Arterial blood samples for determination of base excess (BE) and bicarbonate (blood
gas analyzer; Radiometer ABL520, Copenhagen, Denmark), and lactate (enzymatic
assay; Cobas Fara, Roche Diagnostics, Branchburg, USA) were drawn, in parallel with
the 10 min. tonometry interval, before and immediately at the end of the 10 min.
exercise episode. Rapid serial lactate measurements were performed using a small
portable lactate analyser (Accutrend, Roche Diagnostics, Almere, the Netherlands),
specifically developed for use during exercise testing. Using this device, measurement
results were available within 60 sec. after blood sampling.
The tests evaluated in the present study were all aimed at a submaximal level: lactate
level (or BE-decrease) at or just above 4 mmol/l (the anaerobic threshold) and not ex-
ceeding 8 mmol/l. After comparison with arterial lactate measurements (see results
section), BE-decrease during exercise was used as the parameter assessing the exercise
intensity. The optimal exercise level was a BE-decrease between 3 and 7 mmol/l. Less
than 3 mmol/l and more than 7 mmol/l were regarded as low resp. high exercise levels.
For comparing the results of HR- and RQ-measurements with BE-decrease as the in-
dicator of the exercise intensity reached, the following parameters were used: maximum
RQ reached (RQmax), total time of RQ>1 (RQt>1), maximum heart rate reached (HRmax)
as percentage of HRmaxpred, and total time of HR>80% of HRmaxpred (HRt>80).
Statistics
All values are given as mean ± SD unless otherwise stated. P-values < 0.05 were
considered statistically significant. Correlations between lactate and BE- respectively
bicarbonate-decrease, and between both HR-and RQ-parameters and exercise intensity
as measured by BE-decrease, were calculated using Spearman’s rank test. For
comparison of HR- and RQ-parameters with exercise level (as divided in low, optimal
or high) one-way ANOVA with Bonferroni post-hoc analysis was used. Group
comparisons of the tonometry results of high and low exercise levels vs. all tests and the
diagnostic accuracy of tonometry in the different monitoring episodes were performed
using chi-square testing.
RESULTS
HR-triggering
In 39 tests (10 in healthy volunteers and in 29 patient tests) HR-triggering was used. In
22 (56%) of these HR-triggered tests the mean HR in the last 4 minutes equalled the
target HR of 80% (5%) of HRmaxpred. In 9 tests (23%) the target HR was not reached;
in five of these the subjects were using beta-blocking medication. In 8 tests (20%) HR
was greater than 85% of HRmaxpred. The resulting exercise levels as measured by BE-
decrease are shown in table 2. In three tests the exercise intensity was too low. In two
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the target HR was not reached; one of the subjects used beta-blockers. Two tonometry
results were true negative, the other false positive.
Of the 9 tests with an erroneously high exercise level, in only one test HR was too high.
The other 6 tests in which HR was too high resulted in the submaximal exercise levels
aimed for. When analysing the 110 tests in which both HR and RQ were recorded, only
a weak correlation was observed between both HRmax and HRt>80 and exercise intensity
as measured by BE-decrease (r=0.23 resp. 0.20, p<0.05). There was no significant
difference for the HR-derived parameters when comparing low, target and high
exercise intensity. Figure 1 displays the comparison of HRmax for the three exercise
intensity groups.
Figure 1. HRmax (95% confidence intervals) in low, target and high exercise level.
Exercise level
HighTargetLow
90
80
70
60
Table 2. Resulting exercise intensities for the three triggering regimes.
Exercise level Low Target High
Triggering method BE-decrease: <3 mmol/l 3-7 mmol/l >7 mmol/l
HR (39 tests) 3 (8%) 27 (69%) 9 (23%)*
RQ (84 tests) 8 (10%) 74 (88%) 2 (2%)
Lac (55 tests) 23 (41%)† 29 (53%)* 3 (5%)
values are given as numbers (percentage of total of triggering method);
*p<0.05, † p<0.001 comparing the three different triggering regimes
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RQ-triggering
In 84 tests RQ-triggering was used. In 67 (80%) of these tests the target RQ of 1.0 was
reached while the mean RQ in the last 4 minutes was 1.0 (5%). In 11 tests (13%) the
target RQ was not reached and in 6 tests (7%) the mean RQ in the last 4 minutes
exceeded the target RQ by more than 5%. Of the 8 tests with a low exercise level, the
target RQ was not reached in 4. In both tests with a too high exercise intensity mean
RQ in the last 4 minutes was greater than 1.05.
When analysing all 110 tests in which RQ was monitored, positive correlations were
found for comparing RQmax and RQt>1 and BE-decrease (r=0.34 and 0.38 resp.,
p<0.0005). When divided in low, target and high exercise intensity groups, both RQmax
and RQt>1 showed significant differences between these three groups (p<0.0005; one-
way ANOVA with Bonferroni post-hoc analysis). Figure 2 displays the comparison of
RQmax for the three exercise intensity groups.
Figure 2. RQmax (95% confidence intervals) in low, target and high exercise level.
Exercise level
HighTargetLow
1,3
1,2
1,1
1,0
,9
Lactate-triggering
In 55 tests lactate triggering was used. In 26 of these tests the target lactate level of 4.0
mmol/l in the last 2-4 minutes was not reached. This resulted in BE-decrease below 3
mmol/l in 19 tests. In two tests the rapid lactate measurements exceeded 8 mmol/l at
t=6 or 8 min. In one, the resulting exercise level was too high (BE-decrease >7
mmol/l). Of the 27 tests in which the target lactate levels were reached (at least 4
mmol/l at t=6 or 8, and remaining below 8 mmol/l), the resulting exercise levels were
too low in 7 and too high in 2.
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Arterial lactate vs. BE- and bicarbonate decrease
In 78 tests both arterial lactate levels and blood gas parameters were obtained. A high
degree of correlation between both BE- and bicarbonate-decrease and lactate level after
exercise was found: r=0.93 resp. r=0.89 (p<0.0005). Figure 3 displays the relation
between arterial lactate and BE-decrease after exercise. Mean paired differences
between lactate and BE-decrease were 0.7 (SD 0.7) mmol/l and between lactate and
bicarbonate-decrease 1.4 (SD 0.9) mmol/l.
Figure 3. Relationship between arterial lactate concentration after exercise and BE-
decrease at the end of the exercise period.
Lactate (mmol/l)
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Comparison accurateness of exercise tonometry at low, target and high exercise
levels
As shown in table 2, lactate triggering resulted in significantly more low exercise levels
compared to the other two regimes (p<0.001).
False negative tonometry results were found in 10 (6%) of all tests. Low exercise levels
did not result in an increase in false negative tonometry tests: in only 2 of 10 (5%) false
negative tests the exercise level was too low; one test was RQ-triggered, the other
lactate-triggered.
Tonometry results were false positive in 34 of all 178 tests (19%). Of the 14 tests with a
too high exercise level, in 6 (43%) the tonometry tests were false positive (p<0.001
comparing high exercise level vs. all tests). Three of these tests were HR-triggered (but
HR did not exceed the target HR), 2 RQ-triggered and one was lactate-triggered.
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The sensitivity and specificity of tonometry exercise testing for gastrointestinal ischemia
did not differ among the three groups (82% and 73%, respectively).
DISCUSSION
For optimal diagnostic accuracy, the exercise level in gastric exercise tonometry can be
monitored and adjusted by RQ-measuring, or alternatively by serial arterial lactate
measurement. Although the latter resulted in more tests with lower than desired
exercise levels, this had no influence on diagnostic accuracy.
The greatest problem relating to exercise level in gastric exercise tonometry is the above
submaximal, or maximal, test as this is associated with 43% false-positive tests in this
study. In maximal exercise, splanchnic blood flow is severely reduced, and can be lead
to reduction below the level required to maintain aerobic metabolism. Although data on
the splanchnic vascular responses to maximal exercise have not been established,
ischemia has been established frequently under these circumstances 6,9. In a study on
splanchnic blood flow in trained volunteers, mean SMA blood flow fell by 38-49% after
a 10 min. exercise test at 70% of maximal workload 11. It has been shown that the flow
reduction in the celiac artery exceeds that of the superior mesenteric artery, but still
does not exceed around 50% 10. Therefore the normal splanchnic flow after sub-
maximal exercise remains well above the normal lower level of normal splanchnic
blood flow, which is estimated at approximately 30% of the normal baseline value 2.
This explains why submaximal exercise does not result in ischemia in subjects with
normal splanchnic vessels. Gastric ischemia during submaximal exercise can be seen in
patients with splanchnic stenoses or in patients with reduced cardiac output 5,8. Thus,
for practical clinical purposes 10 min of submaximal exercise seems adequate to
distinguish between normal and pathological gastrointestinal vascular responses.
Some exercise should be performed to allow for blood flow redistribution and
reduction of the splanchnic blood flow, and thus provocation of ischemia. However,
the minimally required level is currently unknown. Even with very low intensity exercise
in healthy humans a significant shift in blood flow from the abdominal viscera to the
exercising muscles was observed 7. Thus submaximal exercise as currently advocated
might not be necessary, and lower lactate levels may suffice for diagnostic testing.
Triggering on RQ-measurements resulted in the highest proportion of tests within the
target range, but has disadvantages. It requires a pulmonary function lab with specific
devices for measurement of exhaled carbon dioxide and inhaled oxygen, making the
test expensive and more complicated. The advantage of RQ-monitoring in minimizing
the proportion of below-target exercise level did not result in a lower number of false
negative tests in this study.
The major advantages of the serial lactate measurement are its simplicity and low cost.
This rapid test can be performed by paramedic personnel and enables determination of
blood lactate levels within 60 seconds. This enables adequate monitoring and triggering
of exercise levels. A gastric tonometry exercise test, a routine procedure in our hospital
in patients suspected of chronic gastrointestinal ischemia, takes 15 min of doctor’s time,
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and 2 hours time for a registered nurse. Moreover, the currently available air tonometry
device allows for accurate and reproducible measurements without the hassle and
problems associated with classically used saline tonometry 4.
In conclusion, by using RQ and serial lactate measurements adequate exercise levels for
gastric exercise tonometry can be achieved. Rapid lactate measurements and the
presented algorithm for gastric exercise tonometry are feasible for the daily clinical
practice.
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ABSTRACT
Background and aims. In most patients with chronic gastrointestinal ischemia the celiac
artery is involved, enabling the use of gastric exercise tonometry as a diagnostic
function test. In this study we investigated the feasibility of combining gastric and
jejunal exercise tonometry and determined the normal values. We investigated the
potential diagnostic value of combining gastric with jejunal exercise tonometry.
Materials and methods. Between 1998 and 2000, combined gastric and jejunal exercise
tonometry tests was performed in a healthy volunteer and in patients suspected of
chronic gastrointestinal ischemia. Using automated air tonometry, gastric (PgCO2) and
jejunal PCO2 (PjCO2) were measured before, during and after 10 min. exercise. Luminal-
arterial PCO2 gradients (gPCO2 resp. jPCO2) were calculated. Final diagnosis of
chronic ischemia was made by our institutional multidisciplinary working group on
gastrointestinal ischemia.
Results. Jejunal tonometry was possible in 25 of 27 subjects. The healthy volunteer was
tested twice, yielding a total of 26 combined tests. Mean normal basal PjCO2 was 0.9 kPa
higher than PgCO2. The calculated upper threshold (mean + 2SD) of normal jPCO2
was 1.4 kPa. In five of 8 patients with chronic gastrointestinal ischemia gastric exercise
tonometry was abnormal, in one both gastric and jejunal tonometry were abnormal, in
two only jejunal exercise tonometry was abnormal.
Conclusion. Combined gastric and jejunal exercise tonometry is a feasible procedure that
is relatively easy to perform. Based on this pilot study, jejunal tonometry seems to have
a small additional value in the diagnosis of chronic gastrointestinal ischemia.
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INTRODUCTION
Gastric exercise tonometry has been shown to be a valuable diagnostic function test for
suspected chronic gastrointestinal ischemia 4,8. For detection of chronic gastrointestinal
ischemia, which usually involves the celiac artery (CA), the easily performed gastric
tonometry measurement may suffice. Although in most patients with symptomatic
ischemia the celiac artery is stenotic or occluded, doubt remains whether exercise
tonometry testing in the stomach alone is sufficient for determining ischemia if the
celiac artery is not involved or not the only vessel involved. It might be expected that
jejunal tonometry measurement -in the flow region of the superior mesenteric artery
(SMA)- could have additive value in patients with (isolated) SMA stenosis or occlusion.
Jejunal tonometry dates back to 1991 when Boley and Brandt described a single case of
chronic gastrointestinal ischemia (3-vessel disease), which was demonstrated by
increased jejunal PCO2 after a test meal 1. Unfortunately, no study determining the
normal values of jejunal tonometry and comparing its results with gastric tonometry has
been performed until now.
We therefore investigated the feasibility of jejunal tonometry, with focus on the
determination of normal values in comparison with gastric tonometry, and comparison
of the results of jejunal with gastric tonometry exercise testing in the evaluation of
patients suspected of having chronic gastrointestinal ischemia.
MATERIAL AND METHODS
Subjects
The combined gastric and jejunal exercise tonometry tests were performed between
1998 and 2000. First, a healthy volunteer (male 25 years) was tested twice: before,
during, and after a 10-min. episode of submaximal as well as maximal exercise.
Thereafter, combined gastric and jejunal tonometry exercise testing was planned in 26
patients (12 male, 14 female; median age 51 yr.; range 34-75) with suspected chronic
gastrointestinal ischemia. All patients were referred to the multidisciplinary working
group on gastrointestinal ischemia in our hospital. Chronic gastrointestinal ischemia
was suspected because of persistent symptoms of abdominal pain, weight loss,
diarrhoea or unexplained gastric ulceration for which no other explanation could be
found despite additional investigations such as endoscopy of upper digestive tract,
colonoscopy, abdominal ultrasound, and abdominal CT-scan.
All patients were evaluated by this working group for clinical suspicion of chronic
gastrointestinal ischemia using a standard protocol. Gastric and jejunal exercise tono-
metry, duplex ultrasonography and visceral angiography were performed.
For the presence or absence of splanchnic stenoses the selective visceral angiography
was used as the gold standard. As there is no gold standard for diagnosing ischemia we
decided to rely on a panel decision 2. Upon discussing each case in the gastro-intestinal
working group a consensus diagnosis was made. As has been described earlier, a careful
follow-up program of all patients irrespective of diagnosis was part of this process 8.
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Thus, the panel had access to all results, including angiograms, duplex and tonometry.
The main criterion was the clinical history (pain provoked by a meal or exercise, weight
loss), exclusion of other causes, and the presence of significant hemodynamic
stenosis 3,4. On follow-up the consensus diagnosis could change based on the clinical
course, treatment results, or alternative diagnosis.
Angiography
The patients underwent multiplane arterial digital subtraction angiography of the
abdominal aorta, in AP and lateral projections in in- and expiration (Philips 3000
Integris system, Philips, Eindhoven, the Netherlands) during injection of 25-40 ml
contrast medium (Ioxaglate, Hexabrix®, Mallinkrodt). The luminal filling of the
abdominal aorta, the celiac, superior, and inferior mesenteric artery was measured. Also
selective catheterisation was performed of the CA, the SMA and the inferior mesenteric
artery (IMA) to detect collateral vessels. Stenoses were graded in consensus by two
independent investigators who were blinded to the patients’ symptoms and the results
of the duplex sonography and exercise tonometry.
Duplex sonography
In all subjects duplex sonography was performed. After a fasting episode of six hours,
the patients were scanned using a 3.5 MHz convex sector probe with a Diasonics VST-
master ultrasonography device. After identifying the vessels and confirming patency
and antegrade flow, the peak-systolic and end-diastolic flow velocities during in- and
expiration were measured in the celiac (CA) and superior mesenteric (SMA) arteries and
the aorta. The Doppler measurements were made with a sample size of 5 mm. Velocity
measurements were taken with the smallest, most accurate flow-to-beam angle possible.
No measurements were accepted if the angle was greater than 60. Peak-systolic flow
velocities below 200 and 275 cm/sec and end-diastolic flow velocities below 55 and 45
cm/sec were regarded as normal for the CA and SMA, respectively 7.
Tonometry
Two standard tonometry catheters (in the first 15 patients: Trip tonometer, sigmoid
model with a blind tip and no central lumen; in the remaining subjects: Datex 8F
pediatry/gastroenterology tonometry catheter with a central lumen allowing insertion of
a guide wire; Datex-Engstrom, Hoevelaken, the Netherlands) were inserted
nasogastrically and placed at 50 cm from the tip of the nose. Under fluoroscopic
guidance, one of these catheters was further inserted and positioned in the jejunum
with its tip past the ligament of Treitz, while ensuring proper placement in the proximal
corpus of the stomach of the second catheter.
Both catheters were attached to automated air tonometry devices (Tonocap, Datex-
Engstrom, Finland), which use a pump to automatically inflate and deflate the
tonometer balloon via an airtight circuit, and analyze PCO2 of the aspirated gas by
infrared capnography. The tonometry devices were set up to measure intragastric PCO2
(PgCO2) and intrajejunal PCO2 (PjCO2) every ten minutes.
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All measurements were made in the afternoon after a fasting episode of 6 hours. One
hour prior to starting tonometry measurements, 100 mg ranitidine was administered
intravenously to prohibit gastric acid formation 11. A radial artery catheter was inserted
in the non-dominant arm to allow arterial blood sampling.
The exercise test was performed on an electromagnetically braked bicycle ergometer
(Lode, Groningen, Netherlands). During the exercise testing a 12-lead electrocardio-
gram was recorded (Case 12, Marquette Electronics Inc., Milwaukee, USA) and breath-
by-breath oxygen uptake (VO2) and respiratory gas exchange ratio (RQ) were measured
by a respiratory gas analyzer system (Oxycon-Jaeger, Bunnik, the Netherlands).
Baseline measurements of arterial blood sampling and gastric and jejunal tonometry
PCO2 were obtained 10 minutes and immediately before the exercise period. The
exercise period lasted 10 minutes and was started immediately after completing the last
baseline tonometry measurement cycle. The workload was increased gradually during
the first 4-5 minutes and targeted at a submaximal work rate level 8,9. RQ was
monitored as an indicator for exercise level and was used to taper the workload, aiming
for an RQ at 1.0. In the healthy volunteer a second exercise test was done aiming at
maximal exercise intensity, as part of a larger volunteer study 9. Arterial and tonometry
parameters were obtained immediately at the end of the exercise period and ten and
twenty minutes after the exercise period. Arterial blood was analyzed immediately for
pH, PCO2, PO2, base excess (BE) and bicarbonate content using a standard blood gas
analyzer (Radiometer ABL520, Copenhagen, Denmark).
Statistics
All tonometry variables are expressed as mean ± standard deviation (SD). Where
appropriate the 95% confidence intervals (95% CI) are given. The normal upper
threshold for jPCO2 was calculated from the normal resting values (mean + 2 SD).
Correlation between tonometry variables was calculated using Pearson's correlation
coefficient. Differences between the tonometry variables were calculated using the
paired Student's t-test. Comparison of the tonometry variables for the different test
episodes (baseline, exercise, recovery) was performed using one-way ANOVA. P-values
<0.05 were considered statistically significant.
RESULTS
Feasibility
In 25 of 27 subjects combined gastric and jejunal tonometry was successfully
performed. The time for the total procedure from the moment of the nasal insertion of
the catheters until achieving proper placement of both catheters varied between 12 and
20 min (median 15 min). Total transillumination time was between 2 and 5 minutes. In
one patient proper placement of the jejunal catheter was not possible because of
persistent curling of the catheter in the proximal duodenum. In one subject the jejunal
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catheter appeared to leak very small amounts of air which made the jejunal tonometry
results unreliable.
Tonometry variables in subjects with normal splanchnic vasculature and
perfusion
For determining normal values only the 12 tests in subjects without splanchnic stenoses
and ischemia and without other possible confounding disorders were taken into
account.
Baseline measurements. In table 1 the normal resting values for PgCO2 and PjCO2 and
luminal-arterial PCO2 gradient (gPCO2 resp. jPCO2) are given. The calculated upper
threshold of normal jPCO2 was 1.4 kPa. As already observed with air tonometry in
healthy volunteers, PgCO2 was slightly lower than arterial PCO2 resulting in negative
gPCO2 9. Mean baseline PjCO2 was 0.9 kPa (95% CI 0.6 - 1.2 kPa) higher than mean
PgCO2 (p<0.0001). A significant correlation between PgCO2 and PjCO2 (figure 1) was
observed (Pearson's correlation coefficient 0.70, p<0.0001). There was no significant
correlation betweengPCO2 andjPCO2 (figure 2).
Table 1. Normal resting values (in kPa) for gastric and jejunal tonometry parameters.
Mean SD 95% CI
PgCO2 5.0 0.7 4.7 - 5.3
PjCO2 5.9 0.9 5.5 - 6.3
gPCO2 -0.5 0.5 -0.7 - -0.3
jPCO2 0.4 0.5 0.2 - 0.6
Exercise and recovery measurements. In 10 subjects a proper submaximal exercise test (BE-
decrease < 8 mmol/l) was obtained. One test in the healthy volunteer was deliberately
aimed at being maximal (BE-decrease 14 mmol/l) and in one patient the exercise
intensity was increased too fast, also resulting in a nearly maximal test (BE-decrease
9 mmol/l). The course of the tonometry variables before, immediately after exercise
and during recovery is displayed in figure 3. For all parameters there were no significant
differences between baseline, exercise and recovery values in the 10 submaximal tests.
The PgCO2 was 4.9 ± 0.7 kPa at baseline (mean of the two baseline measurements),
5.3 ± 0.8 kPa immediately after exercise and 5.0 ± 0.7 kPa after the first 10-min.
recovery. For the PjCO2 the baseline, exercise and recovery values were 5.8 ± 1.0 kPa,
6.1 ± 1.3 kPa, and 5.8 ± 1.3 kPa respectively. The gPCO2 was -0.6 ± 0.5 kPa before,
-0.1 ± 0.7 kPa immediately after and -0.1 ± 0.8 kPa in the first 10 minutes recovery
after exercise. The corresponding values forjPCO2 were 0.4 ± 0.5 kPa, 0.7 ± 0.7 kPa,
and 0.7 ± 0.9 kPa respectively. In none of the subjects with normal vasculature the
normal upper thresholds for gPCO2 of 0.8 kPa and for jPCO2 of 1.4 kPa were
exceeded.
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Figure 1. Normal resting (baseline) gastric vs. jejunal PCO2
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Figure 2. Normal restinggPCO2 vs. jPCO2 (values in kPa)
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Figure 3. Course of gastric and jejunal PCO2 andPCO2 at baseline (1 resp. 2), during
10 min. submaximal exercise, and after 10 and 20 min. recovery (1 and 2) in subjects
with normal splanchnic vasculature. Values are in kPa.
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Tonometry variables in patients with splanchnic artery stenosis or symptomatic
chronic gastrointestinal ischemia
In table 2 the maximalgPCO2 andjPCO2 in patients (n=8) with symptomatic chronic
gastrointestinal ischemia (7 with ischemia due to splanchnic artery stenosis, one with
NOMI) and in patients (n=3) with asymptomatic splanchnic artery stenosis.
Of the eight patients with ischemia, gastric exercise tonometry detected six. Two
patients with a negative gastric exercise test were found only with jejunal tonometry:
one with CA stenosis only (suggesting intrasplanchnic steal) and one with both CA and
SMA stenosis. The other way around, jejunal tonometry was abnormal in only three of
the eight patients with symptomatic gastrointestinal ischemia.
In one subject isolated SMA stenosis was found. This patient had no symptomatic
ischemia and both gastric and jejunal tonometry was normal.
In the subject with NOMI vascular spasms (without fixed stenosis) were demonstrated
by angiography. In this subject gastric but not jejunal ischemia was found with exercise
tonometry.
Table 2. Tonometry results in eleven patients with splanchnic artery stenosis and/or
symptomatic chronic gastrointestinal ischemia.
M/F age Stenosis Ischemia MaxgPCO2 MaxjPCO2
1 M 55 CA/SMA Yes (0.9) n (1.3)
2 M 48 CA/SMA Yes n (0.3) (1.4)
3 F 58 CA/SMA Yes (1.3) n (1.3)
4 F 64 CA/SMA Yes (1.5) (2.5)
5 F 58 CA Yes (0.8) n (0.0)
6 M 34 CA Yes n (-0.4) (1.8)
7 F 37 CA Yes (0.9) n (0.5)
8 F 37 CA No n (0.5) n (1.0)
9 M 48 CA No n (0.0) n (1.2)
10 M 68 SMA No n (0.7) n (0.7)
11 M 40 none (NOMI) Yes (1.3) n (1.0)
Max.gPCO2 and max.jPCO2 are displayed as: normal (n) or elevated (), the values
are enclosed in parentheses.
Tonometry variables in other disorders
Table 3 displays maximal gastric and jejunal PCO2 in 3 subjects with various other
conditions leading to impaired gastrointestinal perfusion. One patient had ischemic
colitis as presenting complaint; no splanchnic stenoses were found on angiography.
Later analysis revealed cardiac disease leading to forward failure analysis, which was
previously not recognized. This forward failure led to gastrointestinal ischemia during
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exercise 6. A second patient was treated with iloprost because of suspected vasospasms.
During exercise he became hypotensive, which probably resulted in the gastrointestinal
ischemia we observed. In one subject with small bowel Crohn's disease a marked
increase of an already elevated resting jejunal PCO2 gradient (mean baseline jPCO2 of
3.2 kPa) was observed, while gastric tonometry variables were normal.
Table 3. Tonometry results in other disorders.
M/F age Diagnosis MaxgPCO2 MaxjPCO2
12 F 68 Ischemic colitis, cardiac failure (forward
failure, hypotension)
2.6 2.6
13 F 65 Crohn's disease of small bowel 0.6 4.3
14 M 53 Iloprost infusion, hypotension 1.8 2
DISCUSSION
The present study suggests that combining gastric and jejunal exercise tonometry may
have additional value in the diagnosis of chronic gastrointestinal ischemia as compared
to gastric tonometry only. However, in this small study, gastric exercise tonometry
would have detected 6 of 8 patients, while jejunal tonometry alone would have detected
only 3 of 8. Thus, its role is probably confined to additive of gastric tonometry, not a
replacement.
It might be expected that jejunal measurement is abnormal in patients with ischemia
due to isolated SMA stenosis or occlusion. But as none of the patients in the present
study had isolated due to SMA stenosis this hypothesis could not be proven. However,
in two of the eight subjects with symptomatic chronic gastrointestinal ischemia gastric
tonometry testing showed normal results, while jejunal exercise tonometry parameters
were abnormal. In one subject an isolated CA occlusion was found, in the other
stenosis of both CA and SMA. In the latter patient it may be postulated that ischemia
occurs in the flow area of the SMA whereas in the stomach (the flow area of the CA)
no ischemia is provoked by exercise. The finding that exercise induced jejunal but not
gastric ischemia in the case of isolated CA stenosis, might be explained by the
occurrence of intrasplanchnic steal, where -in response to exercise- the jejunal blood
flow is compromised if favor of the collateral gastric perfusion. Alternatively, it may be
postulated that gastric tonometry values were erroneously low (by air swallowing for
example) yielding false-negative gastric tonometry results.
Our present study demonstrates that jejunal placement of a standard nasogastric
tonometry catheter is a feasible procedure. Although the procedure is easily performed,
most patients experienced mild to moderate discomfort in the nasopharyngeal area
when the jejunal catheter was manipulated to further advance it into the small bowel. In
one subject minuscule leakage of air from the closed tonometry circuit (via the jejunal
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tonometry catheter) was observed, yielding very low P jCO2 values of 0.1 – 0.2 kPa. The
results from this patient were discarded from analysis in this study.
In a previous study of our group, a normal upper threshold for gPCO2 after
submaximal exercise of 0.8 kPa was found 5,9. For jejunal tonometry an upper normal
threshold of 1.4 kPa was calculated. Indeed, in the present study in none of the subjects
with normal vasculature during and after exercise the normal upper thresholds for
gPCO2 andjPCO2 were exceeded in this study.
It was found that normal resting PjCO2 values were 0.8 (SD 0.7, 95% CI 0.6 – 1.2) kPa
higher than PgCO2. Several possible explanations may be postulated to explain this
discrepancy between gastric and jejunal PCO2.
Duodenal bicarbonate secretion via the bile together with small amounts of acid
passing from the stomach may result in excess formation of carbon dioxide in the small
bowel. In the fasting state the intraluminal duodenal pH varies between 2 and 6 10.
These fluctuations are reduced or even completely buffered in the distal duodenum and
proximal jejunum. The PCO2 measured in the proximal jejunum might be the result of
propulsion of carbon dioxide produced in the duodenal bulb by peristalsis.
Alternatively, swallowing of air may result in dilution of the CO2 concentration of
intragastric gas, while not affecting PCO2 of the jejunum. This phenomenon may also
explain the finding that intragastric PCO2 is slightly lower than arterial PCO2, resulting in
negative baseline gPCO2 values. Similar as previously observed in one subject in a
volunteer study, in the present study in one subject all intragastric PCO2 values were
lower than arterial PCO2 values 9. Indeed, air-swallowing may be the most plausible
explanation for this finding.
Apart from being an additional diagnostic tool in (suspected) chronic gastrointestinal
ischemia, jejunal tonometry might be of interest in several other conditions. In
situations of "global" hemodynamic instability it was found that jejunal tonometry
closely paralleled gastric tonometry results. Interesting observations were made in a
patient with Crohn's disease of the small bowel. Gastric tonometry results were normal
whereas jejunal tonometry demonstrated that already at rest ischemia was present,
which worsened during exercise. These findings support the hypothesis of significant
local vascular involvement in Crohn's disease 12.
In conclusion, this study demonstrates that combining gastric with jejunal exercise
tonometry testing is a feasible procedure that is relatively easy to perform and may
contribute to the diagnosis of gastrointestinal ischemia. Normal resting jejunal PCO2
values were 0.8 kPa higher than gastric PCO2. The calculated normal upper threshold of
the jejunal-arterial PCO2 gradient of 1.4 kPa was not exceeded during and after exercise
in subjects with normal splanchnic vasculature. Apart from having additional value in
demonstrating jejunal ischemia in subjects with chronic gastrointestinal ischemia, the
technique may be used to demonstrate ischemia in other disorders such as
hemodynamic instability and Crohn's disease.
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ABSTRACT
Background and aims. Chronic gastrointestinal ischemia or chronic splanchnic syndrome
is a difficult diagnosis. The use of a physiological test, combined with clinical and
anatomical data should improve diagnostic accuracy. This study evaluates the diagnostic
accuracy, and clinical impact of gastric exercise tonometry in a patient cohort suspected
of chronic splanchnic syndrome.
Methods. From 1997 – 2000, 102 patients with chronic abdominal pain were analysed.
The workup included gastric exercise tonometry and selective biplane angiography. The
diagnosis chronic gastrointestinal ischemia was based on consensus in a
multidisciplinary working group and sustained on follow-up.
Results. Gastrointestinal ischemia was diagnosed in 38 patients. In 33 patients chronic
splanchnic syndrome was found, with single vessel involvement in 20 (17 celiac artery,
3 mesenteric superior), and multivessel disease in 13. In 5 patients nonocclusive
ischemia was found. By using receiver operator curve analysis, the difference between
gastric and arterial partial pressure of carbon dioxide (PCO2 gradient) proved to be the
best exercise tonometry parameter. The criteria for diagnosing ischemia in gastric
exercise tonometry were: PCO2 gradient > 0.8 kPa and increase gastric PCO2, with base
excess decrease < 8 mmol/l during exercise. Gastric exercise tonometry had 78%
sensitivity and 92% specificity. Twenty-five patients underwent vascular treatment (19
operative, 6 stent / PTA). After 4 years of follow-up 83% of patients were alive and
free of symptoms.
Conclusions. Gastric exercise tonometry is an accurate diagnostic tool to show
gastrointestinal ischemia. Including gastric exercise tonometry into clinical decision
making enabled selecting patients with ischemia, who benefited from vascular and
medical treatment. These benefits were sustained during 4-year follow-up. Gastric
exercise tonometry should be considered in the workup of patients with a suspected
diagnosis of gastrointestinal ischemia.
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INTRODUCTION
The diagnosis of chronic gastrointestinal ischemia is notoriously difficult. Many patients
with splanchnic stenoses remain asymptomatic and have no indication for treatment.
Other patients develop typical symptoms, including postprandial pain, fear of eating,
and weight loss, a condition referred to as chronic splanchnic syndrome or chronic
mesenteric ischemia. Another patient group consist of those with ischemia and appa-
rently normal splanchnic vessels, a condition referred to as non-occlusive mesenteric
ischemia (NOMI), caused by local vasoconstriction related to circulatory (pre)-shock.
It has been shown that the main contributor to the diagnosis is a high degree of clinical
suspicion 2,6, and that detection of a stenosis alone does not prove ischemia 4,5,21. It is
widely accepted that the gastrointestinal tissue is resistant to ischemia because of the
extensive collateral circulation between the three main arteries 16,19. Common clinical
knowledge thus dictates that at least two of the three major splanchnic arteries have to
be stenotic to give ischemic symptoms. Studies that reported the rarity of an isolated
stenosis of the celiac artery (CA) as cause of complaints 3,20 coincide with series
showing disappearance of symptoms after treatment of isolated CA stenoses 13,15.
Therefore, some but not all patients with splanchnic stenoses benefit from treatment. It
was acknowledged over a decade ago that “a functional and physiological test
distinguishing symptomatic ischemia, the chronic splanchnic syndrome from non-
ischemic stenoses, the chronic splanchnic disease, was urgently warranted” 1. None of
the currently available diagnostic modalities, including angiography, duplex ultrasound
and magnetic resonance angiography, could provide that functional information.
Measurement of intraluminal partial pressure of carbon dioxide (PCO2) by tonometry
has been shown to provide exactly that information, the presence or absence of
ischemia. In a small pilot study we have shown that gastric exercise tonometry was able
to detect actual ischemia 9. We have recently validated this exercise test in healthy
volunteers and established the optimal exercise intensity level as well as normal
threshold values 14.
The current study was performed to establish the role of gastric exercise tonometry
testing for detection of gastrointestinal ischemia in a cohort of patient with unexplained
chronic abdominal symptoms and to establish its clinical impact for these patients.
PATIENTS AND METHODS
In our institution a multidisciplinary working group on gastrointestinal ischemia was
instituted in 1997. All patients were evaluated for clinical suspicion of chronic
gastrointestinal ischemia, or because of an incidental finding of splanchnic stenosis on
abdominal angiography. A standard protocol was used including a detailed history of
complaints by two experienced physicians, duplex ultrasound, splanchnic angiography
and gastric exercise tonometry.
The severity of complaints (upper abdominal pain at “rest”, worsening after meal or ex-
ercise, and diarrhoea) was scored by one of the authors (J.A.O.) using a symptom score:
0 = no complaints, 1 = minor complaints not interfering daily activities, 2 = moderate
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complaints, some restrictions in daily activities, 3 = severe complaints, normal activities
impossible. The body mass index was calculated (weight/square of length), and the
weight loss during the last 6 months was recorded.
Splanchnic angiography
All patients underwent multiplane intra-arterial digital subtraction angiography of the
abdominal aorta and its branches (Philips 3000 Integris system, Philips, Eindhoven, the
Netherlands) during injection of 30 to 40 ml contrast medium (Ioxaglate, Hexabrix®,
Mallinkrodt). First a non-selective anterior-posterior and lateral aortic angiography was
performed, followed by selective canulation of the splanchnic arteries. The luminal
filling of the abdominal aorta, the CA, SMA, and IMA was determined. Stenoses were
graded by consensus of two investigators who were blinded to the patients’ symptoms
and the results of the other investigations. For comparison we graded these stenoses as
absent (no stenoses), insignificant (<50%), mild (50-70%), major (70-99%) and occlu-
sion (100%). Furthermore, the presence or absence of collateral circulation was scored.
Gastric exercise tonometry
Gastric exercise tonometry was performed in the afternoon, after a light breakfast
followed by at least four hours of fasting. To prevent intragastric CO2 production by
buffering of gastric acid, 100 mg of ranitidine was administered intravenously one hour
prior to the baseline tonometry measurements. A standard balloon-tipped tonometry
catheter (Trip sigmoid catheter, Tonometrics, Helsinki, Finland) was inserted
nasogastrically and placed at 55 cm from the tip of the nose. The catheter was attached
to an automated air tonometry device (Tonocap, Datex-Engstrom, Finland) that uses a
pump to automatically inflate and deflate the tonometry balloon via an airtight circuit.
PCO2 of the aspirated gas is analyzed by infrared capnography. The tonometry device
measures gastric PCO2 (PgCO2) every ten minutes.
An intravenous catheter was placed in the forearm for IV administration of ranitidine.
A radial artery catheter was inserted in the non-dominant arm to allow arterial blood
sampling. The exercise period lasted 10 minutes and followed the last baseline
tonometric measurement cycle. Exercise was performed on an electromagnetically
braked bicycle ergometer (Lode, Groningen, Netherlands). During the exercise test a
12-lead electrocardiogram was recorded (Case 12, Marquette Electronics Inc.,
Milwaukee, USA) and breath-by-breath oxygen uptake (VO2) and respiratory gas
exchange ratio (RQ) were measured by a respiratory gas analyzer system (Oxycon-
Jaeger, Bunnik, the Netherlands) in all but the first 19 subjects. The workload during
was gradually increased and targeted at submaximal work rate level. 14 The maximal
workload (Wmax) was estimated using standard criteria, using age, sex, weight and forced
expiratory volume. The exercise episode was started at 10% of Wmax and in the first 4-6
minutes the workload was increased every minute with 10% of Wmax. The workload
was intended to remain constant thereafter at a submaximal exercise level. The exercise
intensity was monitored by measuring HR, aiming for a HR in the last 4-5 minutes of
80% of maximal predicted heart rate (HRmaxpred) and RQ, aiming for an RQ of 1.0 in
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the last 4-5 minutes of the exercise episode. This RQ was chosen as it indicates the
anaerobic threshold.
At these same time points the PgCO2 was measured by the Tonocap, and the gastric-
arterial PCO2 difference or PCO2-gradient was calculated: PCO2 gradient = PgCO2 –
PaCO2. The normal upper threshold value for PCO2 gradient during exercise is 0.8 kPa 14
The mean of both baseline measurements were taken as baseline values (BL). The
decrease in base excess (baseline - exercise BE value) was used as a measure of exercise
intensity as it is closely correlated to arterial lactate levels. All tonometry test results
were reviewed by two investigators blinded for the other clinical data for determination
of interoperator variability.
The gold standard for chronic gastrointestinal ischemia
Selective splanchnic arteriography was used as the gold standard for the presence or
absence of splanchnic arterial stenosis. Because there is no gold standard for diagnosing
chronic splanchnic syndrome we decided to rely on a multidisciplinary panel consensus
and sustained with careful follow-up, an approach used earlier for diagnoses lacking a
gold standard procedure like rheumatoid arthritis 17. After completion of all
investigations, each case was discussed in the multidisciplinary gastro-intestinal working
group and a consensus diagnosis was made. Due to the nature of this procedure,
blinding was impossible. As mentioned, a careful follow-up program of all patients
irrespective of diagnosis was an important part of this process. On follow-up, the
consensus diagnosis could change based on the clinical course, treatment results, or
alternative diagnosis. In the results, the group referred to as “chronic gastrointestinal
ischemia” contains those subjects with a final, unchanged diagnosis. The patients in
whom the diagnosis was changed on follow-up will be reported separately.
Follow-up
All patients with an initial diagnosis of ischemia are seen in our outpatient clinic at least
1-yearly. For the follow-up of the resumed non-ischemic patient group the physicians
of these patients were contacted by letter. The required information consisted of
current health status, abdominal symptoms, the cause of death in the case patient
expired, and the presence of any signs, symptoms or diagnostic procedures indicating
gastrointestinal ischemia.
Statistics
Values are given as mean ± SD unless otherwise stated. P-values < 0.05 were consi-
dered statistically significant. The Mann Whitney test was used for comparing symptom
scores between the groups with and without chronic gastrointestinal ischemia. For all
baseline values the mean of the two consecutive measurements was taken.
Interobserver variability for angiographic stenosis of CA and SMA and for gastric
exercise tonometry results was determined using the Cohen’s kappa test. Differences in
tonometry variables between patients with and without stenosis and ischemia were
calculated using the unpaired Student’s T-test. Association between gastric exercise
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tonometry result and the presence or absence of stenosis and ischemia was tested using
the Fisher exact test. The diagnostic accuracy of gastric exercise tonometry for chronic
gastrointestinal ischemia was measured by ROC-analysis. The differences between
curves were determined by comparison of the area under the curve and standard error.
The sensitivity, specificity, positive and negative predictive values, as well as likelihood
ratios were calculated. The outcome of patients treated for stenoses were determined by
the life-table analysis according to Kaplan-Meier, using a log rank test.
Table 1. Demographics and clinical presentation (diagnosis gastrointestinal ischemia)
all subjects
(n=102)
chronic GI
ischemia#
(n=38)
no ischemia
(n=64)
Male / female 34 / 68 7 / 31 26 / 37 **
Age (mean, range) 52 (20 - 81) 52 (24 – 75) 52 (20 – 81)
Abdominal pain % (median score) 66% (0.8) 63% (0.8) 66% (0.8)
Pain after exercise % (median score) 47% (0.7) 55% (0.9) 41% (0.7)
Pain after meal % (median score) 72% (1.4) 82% (1.8)* 64% (1.2)
Weight loss % (median score) 59% (1.3) 66% (1.5) 53% (1.2)
Diarrhoea 18% 24% 14%
Ulcer, non-Hp, non-NSAID 11% 13% 9%
Classic trias 32% 42% 27%
symptom scores ranged from 0-3 (see Methods)
# patients diagnosed as chronic gastrointestinal ischemia, sustained during follow-up.
**p<0.05 comparing ischemic and non-ischemic patients (Chi-Square test)
*p<0.05 comparing ischemic and non-ischemic patients (Mann Whitney test)
RESULTS
Patients and symptoms
Between 1997 and 2000, 102 patients (67F/35M, median age 52, range 20-81 yr) were
evaluated. The clinical presentation (symptom scores) and demographic data of patients
who were finally classified as having chronic gastrointestinal ischemia or no ischemia
are summarized in table 1. The presenting complaints were comparable, only postpran-
dial pain was more pronounced in the ischemia group.
The complaints of the 38 patients with chronic gastrointestinal ischemia consisted of
abdominal pain in 36 (95%), weight loss in 25 (66%), and diarrhoea in 3 (8%). The
abdominal pain was provoked by meals in 83%, by exercise in 60%, and occurred at
rest in 67%. In chronic gastrointestinal ischemia more severe postprandial pain was
reported: grade ≥2 in 71% of the ischemia patients compared to 42% in the non-
ischemic group (p<0.05). No differences in body mass index (22.5 kg/m2 in both
groups), BMI below 20 (34.2% vs. 29.7%), and weight loss was seen between the
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ischemic and non-ischemic group. Gastric or duodenal ulcers, not explained by Hp-
infection, medication or malignancy, were found in 12% in chronic mesenteric ischemia
vs. 9% in the non-ischemic group (n.s.).
Splanchnic angiography
In 47 of 102 patients one or more significant stenoses were found; in 42 of 47 the
stenosis was > 70%. Collateral vessels were found in 29 of the 47 patients with stenoses
and in 11 of the 55 patients with normal vessels (p<0.0001). The interobserver agree-
ment for detection of a stenosis in the CA, the SMA and the presence of collaterals was
good with kappa values of 0.71, resp. 0.77 and 0.63 (p<0.001 for all kappa values).
The vascular abnormalities of the 38 patients with a final diagnosis of chronic
gastrointestinal ischemia are summarized in table 2. In 2 of 5 patients without stenoses,
abundant vasospasm was seen during angiography.
Table 2. Vascular involvement in gastrointestinal ischemia patients.
Chronic gastrointestinal ischemia (n=38)
Single vessel 20
CA 17
SMA 3
Multivessel 13
CA/SMA 10*
CA/IMA 0
CA/SMA/IMA 3
No stenosis 5#
* one subject had SMA-stenosis >70% plus CA-stenosis 50-70%
# 5 subjects with suggested gastric vasospasm; in 2 spasms were seen on angiography
Gastric exercise tonometry
In 98 patients (96%) gastric exercise tonometry was interpretable. In 4 patients the level
of exercise was above the goal range (BE-decrease 8 mmol/l). These four tests were
excluded from analysis because we have previously shown false-positive tests in 45% of
subjects at these exercise levels 14.
The final diagnosis of GI ischemia was made and sustained in 38 patients. Of these 33
had splanchnic stenoses (chronic splanchnic syndrome) and 5 had NOMI 10. The PgCO2
and PCO2 gradient differed between patients with chronic splanchnic syndrome, NOMI
and those without ischemia (p<0.0001). The PCO2 gradient in patients with chronic
splanchnic syndrome was higher compared to those without ischemia: (1.20.6 vs.
0.30.7 kPa, p<0.0005), with similar exercise levels (BE-decrease 5.11.7 vs. 4.51.9;
n.s.). The PCO2 gradient in patients with NOMI was higher than in the non-ischemic
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group (1.3±0.3 vs. 0.3±0.7 kPa, p<0.01), but not different from the chronic splanchnic
syndrome patients.
The diagnosis of NOMI was explained by pronounced vasospasm, seen on
angiography in 2 patients. One patient had ischemia from cardiac failure, a condition
known to cause NOMI 12. In 2 others in whom vasospasm was suspected, nitrates were
prescribed; both reported >50% reduction of pain, on a visual analogue scale, sustained
after > 4 year follow-up.
Figure 1. ROC (Receiver Operater Curve) of three tonometry parameters used in the
diagnosis of splanchnic ischemia.
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Gastric exercise tonometry criteria
To establish the best tonometric parameter we compared the maximum gastric PCO2,
the increase of gastric PCO2, the PCO2 gradient and the area under the curve of the
PCO2 gradient (AUCPCO2-gradient). ROC analysis demonstrated that PCO2 and AUC were
the best parameters for demonstrating ischemia (figure 1) and proved better than the
PgCO2 (p<0.001), but not different from the AUCPCO2-gradient (p=0,71). The AUCPCO2-gradient
was significantly better than the gastric PCO2 (p<0.05).
In 8 patients the increased PCO2 gradient during exercise was based on a decreased arte-
rial PCO2 alone, without concomitant increase in gastric PCO2. This was caused by exer-
cise-induced hyperventilation. Only 1 of these 8 was diagnosed with chronic gastroin-
testinal ischemia. Our current data re-establish the previously estimated threshold value
of 0.8 kPa as upper level of normal PCO2 gradient, with an optimal accuracy (figure 2).
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Figure 2. Relation between the threshold PCO2 gradient, sensitivity (sens) and
specificity (spec) for detection of gastrointestinal ischemia.
Taken together, an abnormal gastric exercise tonometry result can best be defined by
three criteria: an increase in gastric PCO2 exercise from baseline to exercise, a PCO2
gradient > 0.8 kPa during exercise, and a BE-decrease < 8 mmol/l during exercise.
Using these three criteria, tonometry was abnormal in 29 of 38 patients with final
consensus diagnosis of chronic gastrointestinal ischemia and in 5 of 64 patients without
(accuracy 86%). The sensitivity and specificity of gastric exercise tonometry for chronic
gastrointestinal ischemia were 78% and 92%, respectively; the positive and negative
predictive values were 85% and 86%, respectively; the likelihood ratio for detection of
gastrointestinal ischemia was 9.6.
Follow-up
The diagnosis on follow-up. Initially gastrointestinal ischemia was diagnosed in 43 patients;
after a follow-up of mean 50 months (range 33-81), the diagnosis was abandoned in 5
patients. The reasons to abandon the initial diagnosis were: lack of improvement
despite adequate stent placement (n=2), development of complaints typical for IBS and
atypical for ischemia (relation to stool passage, bloating and distended abdomen, n=3).
Of the 64 patients without ischemia, 59 with initial classification as non-ischemic and 5
re-assigned to this group during follow-up, follow-up data were available in 55 after
mean 5.5 years (range 3.8-7.7 yrs). None of these developed symptoms fitting acute or
chronic splanchnic syndrome, three died of an unrelated course. Nine were lost to
follow-up because neither we, nor the primary physician or referring physician were
informed on their whereabouts.
Treatment results on follow-up. Of the 38 patients with chronic gastrointestinal ischemia 33
had chronic splanchnic syndrome and 5 NOMI. Twenty-five patients with chronic
splanchnic syndrome underwent vascular treatment. The 8 non-treated patients
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consisted of 3 patients with CA stenosis and mild complaints, who preferred
conservative treatment with frequent small meals and proton pump inhibition over
surgery. In 5 patients with chronic splanchnic syndrome a vascular procedure was
clearly indicated but not performed. Two of these died from bowel infarction within
weeks after diagnosis, while waiting for surgery, all had multivessel involvement. Of the
remaining three, the operative risk was considered too high, whilst the stenoses were
unfitted for stent placement (n=1), or they refused further treatment (n=2).
Of the 25 treated patients 19 were treated operatively, and 6 were treated by endo-
vascular stent placement (n=5) or percutaneous transluminal angioplasty (PTA) alone
(n=1). All 5 patients treated by PTA/stent placement showed good improvement. The
patient treated by PTA alone had only a temporary response, but no further treatment
was considered because of serious concomitant disease (metastatic lung cancer). Of the
19 operated patients, 3 died in the perioperative period from multiple-organ failure.
One was severely cachectic (body mass index 16.0 kg/m2), and 2 had prolonged periods
of abdominal vascular rest pain indicating acute-on-chronic gastrointestinal ischemia.
The remaining 16 had uneventful postoperative course and improvement of symptoms
was documented in all. Two patients treated for multivessel disease died on follow-up:
one had a graft occlusion and subsequent bowel infarction 1.2 years after surgery,
another died from unrelated cause 3 years later.
The outcome of the 12 treated single-vessel patients was quite different from the 13
patients with multivessel disease. Of single vessel patients none died, and the 1-yr
success in this series was 100%, dropping to 79% after 4 years because of symptom
recurrence from stent failure (n=1) or restenosis of the autogenous reconstruction
(n=1) after more than 2 years. In the latter patient, endovascular dilatation relieved
symptoms again. In the multivessel patients 5 patients died, 3 perioperative and 2
during follow-up. All surviving patients with multivessel chronic splanchnic syndrome
were free of symptoms. Thus after 4 years follow-up, all surviving multivessel patients
were symptom free; as well as 79% of the single-vessel patients. Taken together 10/12
(83%) of patients alive at 4 years were free of symptoms.
DISCUSSION
The current study was performed to establish the role of gastric exercise tonometry for
detection of gastrointestinal ischemia in a cohort of patient with unexplained chronic
abdominal symptoms, and to establish its clinical impact for these patients. This study
confirmed that gastric exercise tonometry test can indeed detect gastrointestinal
ischemia, both chronic splanchnic syndrome and NOMI. This is the first study to show
the clinical impact of gastric exercise tonometry, because the inclusion of the results of
this functional test to standard clinical and anatomical data in treatment decision,
resulted in pain relief in 83% of patients sustained after 4-years of follow-up
Tonometry has the unique capability that it can show actual ischemia, for whatever
cause, and regardless of blood flow and metabolic activity 10,11. During ischemia the
tissue PCO2 rises over the normal levels from reduced tissue CO2 washout by the
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lowered blood flow and increased CO2 production during anaerobic metabolism. Thus,
an increased gastric-arterial PCO2 level indicates local production, and therefore
ischemia in practically all shock and ischemia models 11. The gastric PCO2 can be
measured conveniently using air tonometry with small nasogastric catheters and a semi-
automated capnograph. The use of test meal as provocative test seems more obvious, it
proved unreliable 8, and we therefore explored exercise as provocative test. In a pilot
study, gastric exercise tonometry could successfully detect ischemia in 7 chronic
splanchnic syndrome patients 9 and was later validated by us in healthy volunteers 14.
The current study underscores the clinical usefulness and applicability of gastric
exercise tonometry, with 96% interpretable tests, 86% accuracy, and no complications.
In 9 patients gastric exercise tonometry was normal, despite gastrointestinal ischemia.
Two of these patients were unfit to exercise because of underlying severe pulmonary
emphysema. In one patient with isolated SMA stenosis, a second tonometer, placed in
the jejunum as part of a feasibility test to small bowel tonometry, showed a peak jejunal
PCO2 gradient 1.9 kPa, indicating small bowel ischemia. In another patient 24-hour
tonometry, as part of another pilot study, showed repeated peaks in both gastric and
jejunal PCO2 gradients up to 8.0 kPa, correlating with abdominal pain episodes. Also,
the higher frequency of false-negative tonometry among patients who did report
exercise-induced pain indicates that measurement after meals still might be worthwhile.
These findings indicate that the accuracy of exercise tonometry testing may further
improve with 24-hour measurements, and small bowel tonometry.
In the current study most patients with chronic splanchnic syndrome had single-vessel
disease, whereas many others reported this syndrome predominantly in 2- or 3-vessel
disease 2. The 1- and 2- to 3-vessel involvements represent different clinical entities. In
our series, approximately 50% of 1-vessel patients had chronic splanchnic syndrome,
compared to 90% of subjects with 2- to 3-vessel stenoses. Complications, especially
bowel infarction, were common in 2- to 3-vessel patients and absent in those with 1-
vessel stenosis. The symptomatic response to treatment, however, was comparable with
disappearance of symptoms in both groups. This difference might have a major impact
on diagnosis and treatment options. Diagnosing ischemia in patients with 2- to 3-vessel
stenoses often will be right, even without a proper ischemia-specific test. In 1-vessel
disease, diagnosing chronic splanchnic syndrome without a test like gastric exercise
tonometry can feel like tossing a coin, a 50% chance and no clue on how it will turn
out. Thus, especially in this group, gastric exercise tonometry has additional value over
angiography.
The perioperative mortality was rather high in this study, with 3 of 19 patients dying
days to weeks after operation. Three factors could be identified explaining this mortality
figure. First, two of three patients were operated for acute-on-chronic chronic splanch-
nic syndrome, with prolonged and intensified bowel pain, increased lactate levels and
leukocyte counts. During surgery a pale-bluish bowel was notably present in these
patients; the procedures itself went well, but all died from multiple organ failure within
21 days after surgery. It could therefore be argued if these are still chronic ischemia
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patients or already acute infarction or acute on chronic ischemia, known for its very
high mortality of 80% or above 18. Second, the third patient was extremely cachectic,
she had an uneventful surgical procedure, but died from multiple organ failure 2 weeks
post-procedure. Probably, the surgical procedures which consisted of aortic clamping
above the level of the splanchnic arteries may just have been too much for this patient
group. The third factor may thus be the procedure of choice. It is conceivable that less
invasive procedures, like stent placement 22 or retrograde bypasses coming from the
iliac vessels, could reduce this mortality figure in this high-risk patient group.
It seems unlikely, but can not fully be excluded, that the patient group whom we
considered asymptomatic might have benefited from vascular treatment as well. During
follow-up we found no evidence of progressive gastrointestinal ischemia, although ad-
mittedly the observation period was relatively short in relation to such developments 21.
The fact that tonometry represents a physiological test for gastrointestinal perfusion
adequacy, and most of the “non-ischemic” patients had normal tonometry seems a
strong argument against treatment of these patients. Still, to rule out a beneficial effect
of vascular treatment in these patients, randomized controlled trials would be needed,
blinded to tonometry results. From an ethical view point, ignoring physiological data
for choosing optimal treatment options in this disorder seems hardly defendable.
In five patients NOMI was diagnosed because the complaints fitted ischemia,
tonometry was abnormal and vessels on angiography were normal. It might be argued
that these patients represent merely false-positive tonometry tests, but several
arguments favour NOMI as diagnosis. NOMI is regularly observed in intensive care
patients, where splanchnic vasoconstriction is an adaptive response to circulatory (pre)-
shock 10. This low-flow mechanism could explain findings in one patient with a cardiac
failure. In 2 others profound vasospasm of smaller branches of the CA during
angiography coincided with abdominal pain, indicating NOMI 2,11. We hypothesized
that vascular spasm might be involved in the complaints of the other patients as well. In
fact, in many vascular beds symptomatic vasospasms are known to cause symptoms,
such as Prinzmetal angina or syndrome X, Raynaud’s disease, and hemiplegic migraine.
Therefore, patients were treated with vasodilators (nitrates in 3, ketanserin in one) and
3 of them showed remarkable improvement of symptoms with more than 50%
reduction of pain within weeks, sustained during follow-up.
CONCLUSION
We have shown that gastric exercise tonometry test is an accurate diagnostic test for
chronic gastrointestinal ischemia in a large cohort of patients, using rigid diagnostic
criteria and careful follow-up. The PCO2 gradient during submaximal exercise enabled
correct diagnosis in 86% of patients. Gastric exercise tonometry enabled identification
of patients with ischemia and normal vessels, due to vascular spasm, which responded
to vasodilator treatment. The clinical impact of incorporating tonometry results in
decision making was very significant because 83% of patients treated for ischemia were
free of symptoms after 4 years follow-up.
Validation in patient cohort 91
REFERENCES
1. Boley SJ, Brandt LJ, Veith FJ, Kosches D, Sales C. A new provocative test for
chronic mesenteric ischemia. Am J Gastroenterol 1991;86(7):888-91.
2. Brandt LJ, Boley SJ. AGA technical review on intestinal ischemia. American
Gastrointestinal Association. Gastroenterology 2000;118(5):954-68.
3. Geelkerken RH, van Bockel JH, de Roos WK, Hermans J. Coeliac artery
compression syndrome: The effect of decompression. Br J Surg 1990;77(7):807-
809.
4. Geelkerken RH, van Bockel JH, de Roos WK, Hermans J, Terpstra JL. Chronic
splanchnic syndrome, results of reconstructive surgery. Archives of Surgery
1991;126:1101-1106.
5. Järvinen O, Laurikka J, Sisto T, Salenius J-P, Tarkka MR. Atherosclerosis of the
visceral arteries. Vasa 1995;24:9-14.
6. Jaxheimer EC, Jewell ER, Persson AV. Chronic intestinal ischemia. The Lahey
Clinic approach to management. Surg Clin North Am 1985;65(1):123-30.
7. Johnson BA, Weil MH. Redefining ischemia due to circulatory failure as dual
defects of oxygen deficits and of carbon dioxide excess. Crit.Care Med.
1991;19:1432-1438.
8. Kolkman JJ, Groeneveld AB, Meuwissen SG. Effect of gastric feeding on
intragastric PCO2 tonometry in healthy volunteers. J Crit Care 1999;14(1):34-8.
9. Kolkman JJ, Groeneveld ABJ, van der Berg FG, Rauwerda JA, Meuwissen SGM.
Increased gastric PCO2 during exercise is indicative of gastric ischaemia: a
tonometric study. Gut 1999;44:163-167.
10. Kolkman JJ, Mensink PB. Non-occlusive mesenteric ischaemia: a common
disorder in gastroenterology and intensive care. Best Pract Res Clin Gastroenterol
2003;17(3):457-73.
11. Kolkman JJ, Otte JA, Groeneveld AB. Gastrointestinal luminal PCO2 tonometry:
an update on physiology, methodology and clinical applications. Br J Anaesth
2000;84(1):74-86.
12. Krack A, Richartz BM, Gastmann A, et al. Studies on intragastric PCO2 at rest and
during exercise as a marker of intestinal perfusion in patients with chronic heart
failure. Eur J Heart Fail 2004;6(4):403-7.
13. Loffeld RJLF, Overtoom HAJM, Rauwerda JA. The celiac axis compression
syndrome, report of 5 cases. Digestion 1995;56:534-537.
14. Otte JA, Oostveen E, Geelkerken RH, Groeneveld AB, Kolkman JJ. Exercise
induces gastric ischemia in healthy volunteers: a tonometry study. J Appl Physiol
2001;91(2):866-71.
15. Reilly LM, Ammar AD, Stoney RJ, Ehrenfeldd WK. Late results following ope-
rative repair for celiac artery compression syndrome. J Vasc Surg 1985;2(1):79-91.
16. Rosenblum JD, Boyle CM, Schwartz LB. The mesenteric circulation. Anatomy
and physiology. Surg Clin North Am 1997;77(2):289-306.
17. Saraux A, Berthelot JM, Chales G, et al. Ability of the American College of
Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early
arthritis and classification of these patients two years later. Arthritis Rheum
2001;44(11):2485-91.
Chapter 692
18. Schoots IG, Koffeman GI, Legemate DA, Levi M, van Gulik TM. Systematic
review of survival after acute mesenteric ischaemia according to disease aetiology.
Br J Surg 2004;91(1):17-27.
19. Stanton PE, Jr., Hollier PA, Seidel TW, Rosenthal D, Clark M, Lamis PA.
Chronic intestinal ischemia: Diagnosis and therapy. J Vasc Surg 1986;4(4):338-344.
20. Szilagyi DE, Rian RL, Elliott JP, Smith RF. The cardiac artery compression
syndrome: does it exist? Surgery 1972;72(6):849-63.
21. Thomas JH, Blake K, Pierce GE, Hermreck AS, Seigel E. The clinical course of
asymptomatic mesenteric arterial stenosis. J Vasc Surg 1998;27(5):840-4.
22. Van Wanroij JL, Van Petersen AS, Huisman AB, et al. Endovascular treatment of
chronic splanchnic syndrome. Eur J Vasc Endovasc Surg 2004;28(2):193-200.
What is the Best Diagnostic Approach for Chronic
Gastrointestinal Ischemia?
Johannes A. Otte, Robert H. Geelkerken, Ad B. Huisman, Jeroen J. Kolkman
Submitted
Chapter 794
ABSTRACT
Background. Chronic gastrointestinal ischemia is still a difficult diagnosis to establish.
The diagnosis depends on a high degree of clinical suspicion as well as selective
angiography. Duplex sonography may serve as a screening tool, providing information
on splanchnic vessel patency and flow patterns. Gastric exercise tonometry is a
minimally invasive test that can be used for diagnosis in patients with chronic
gastrointestinal ischemia, and can differentiate between symptomatic and asymptomatic
splanchnic artery stenosis. In the present study we compared four different diagnostic
approaches.
Methods. Between 1997 and 2000 84 patients were evaluated for suspected chronic
gastrointestinal ischemia. All underwent splanchnic arterial angiography, duplex
sonography and gastric exercise tonometry. For the presence or absence of stenosis
angiography was used as golden standard. For diagnosing ischemia we relied on a panel
decision. The diagnostic approaches studied were: 1) angiography, only in patients with
classic abdominal angina, 2) screening with duplex sonography, angiography if
sonography abnormal or unreliable, 3) screening with gastric tonometry and
angiography if tonometry not normal, 4) both gastric tonometry exercise and duplex
sonography, angiography if one of both screening tests not normal.
Results. In 28 patients chronic gastrointestinal ischemia was diagnosed. Using clinical
suspicion only, 16 patients (57%) would have been missed. Screening by duplex
sonography or gastric tonometry only would have missed 4 respectively 6 patients.
Screening with combined gastric tonometry and duplex sonography would not have
missed patients with symptomatic ischemia, while 21% of angiographies would have
been avoided.
Conclusion. Screening by combined gastric exercise tonometry and duplex sonography
has excellent diagnostic accuracy. Currently, this approach represents the best
diagnostic work-up strategy in patients with suspected chronic gastrointestinal ischemia.
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INTRODUCTION
Chronic gastrointestinal ischemia is a relatively rare disorder, which is difficult to
establish and often has considerable doctor’s delay. Its diagnosis is currently based on a
high degree of clinical suspicion, e.g. the recognition of the classical clinical
presentation of abdominal angina and requires angiography 2. The use of duplex
sonography of the celiac artery (CA) and superior mesenteric artery (SMA) is
commonly advocated as an alternative, non-invasive, screening test 5. Although
generally available it is still sparsely used for this purpose however, partly because
duplex of the splanchnic arteries is operator dependent and mainly because the
presence of a stenosis does not automatically indicate ischemia. It is assumed that many
patients with splanchnic stenoses never develop ischemia and stay asymptomatic.
Gastrointestinal tonometry is at present the only available test modality that can
demonstrate actual ischemia 2,11. In gastrointestinal tonometry luminal PCO2 is
measured and compared to blood values. In even the earliest stages of ischemia luminal
PCO2 rises over arterial blood PCO2 9. This physiological background makes tonometry
a unique and very sensitive measurement technique for ischemia. We have previously
demonstrated the optimal conditions for tonometry, including acid suppression, use of
meals and normal values in humans 9. Tonometry after food provocation as diagnostic
test for chronic mesenteric ischemia resulted in varying and disappointing
accuracies 1,3,4. These poor results were explained by volunteer studies showing poorly
predictable tonometry parameters during and after meals, due to acid secretion, CO2
dilution and gastric volume effects 6. We therefore shifted our efforts to an alternative
provocative manoeuvre for tonometric detection of ischemia and used a standardised
exercise protocol instead with promising results 7,11,12.
In our clinic we perform duplex ultrasound, selective multi-plane visceral angiography,
and gastric exercise tonometry in all patients suspected for chronic gastrointestinal
ischemia. Still, for future use it is unclear if all of these techniques should indeed be
used, and in which order or combination, for optimal accuracy and minimal costs and
patient burden.
Using the results of our patient cohort we studied four different approaches using these
test modalities (see figure 1).
PATIENTS AND METHODS
Eighty-four patients (58F, 26M; mean age 52, range 20-81 yrs) were examined between
1997 and 2000 for suspected chronic gastrointestinal ischemia. Most of the patients in
this study have been previously described in a publication of our group investigating the
diagnostic value of gastric exercise tonometry 11. All patients had a clinical presentation
of abdominal pain, weight loss and diarrhoea not explained by other investigations
(including esophagogastroduodenoscopy and upper abdominal ultrasound) or
gastroduodenal ulcer not associated with Helicobacter pylori infection or NSAID-use. All
subjects underwent splanchnic arterial angiography, duplex sonography and gastric
tonometry exercise testing.
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For the presence or absence of splanchnic arterial stenosis selective splanchnic
arteriography was used as the gold standard.
As there is no gold standard for diagnosing ischemia we decided to rely on a panel
decision. Upon discussing each case in the gastro-intestinal working group a consensus
diagnosis was made. Due to the nature of this procedure, blinding was impossible. A
careful follow-up program was part of this process, and the consensus diagnosis was
corrected if the data in the follow-up period necessitated this.
Figure 1. Diagnostic approach: suspected chronic splanchic syndrome
Angiography
The patients underwent multiplane arterial digital subtraction angiography of the
abdominal aorta, in AP and lateral projections in in- and expiration (Philips 3000
Integris system, Philips, Eindhoven, the Netherlands) during injection of 25-40 ml
contrast medium (Ioxaglate, Hexabrix®, Mallinkrodt). The luminal filling of the
abdominal aorta, the celiac, superior, and inferior mesenteric artery was measured. Also
selective catheterisation was performed of the CA, the SMA and the inferior mesenteric
artery (IMA) to detect collateral vessels. Stenoses were graded in consensus by two
independent investigators who were blinded to the patients’ symptoms and the results
of the duplex sonography and exercise tonometry.
angiography
strong clinical suspicion
(abdominal angina)
"traditional"
more readily suspicion
unexplained abdominal pain
weight loss, diarrhea, gastric ulcer
screening approach A
duplex sonography
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Best diagnostic approach 97
Duplex ultrasonography
After a fasting episode of six hours, the patients were scanned using a 3.5 MHz convex
sector probe with a Diasonics VST-master ultrasonography device. The duplex
examinations were performed by operators who had no prior knowledge of the
angiographic or tonometry results. After identifying the vessels and confirming patency
and antegrade flow, the peak-systolic and end-diastolic flow velocities during in- and
expiration were measured in the celiac (CA) and superior mesenteric (SMA) arteries and
the aorta. The Doppler measurements were made with a sample size of 5mm. Velocity
measurements were taken with the smallest, most accurate flow-to-beam angle possible.
No measurements were accepted if the angle was greater than 60. Peak-systolic flow
velocities below 200 and 275 cm/sec and end-diastolic flow velocities below 55 and
45 cm/sec were regarded as normal for the CA and SMA, respectively 10.
Gastric tonometry exercise testing
Gastric exercise tonometry was performed in the afternoon, after a fasting episode of at
least four hours following a light breakfast. To prevent intragastric CO2 production by
buffering of gastric acid, 100 mg of ranitidine was administered intravenously one hour
prior to the baseline tonometry measurements. A standard balloon-tipped tonometry
catheter (Trip sigmoid catheter, Tonometrics, Helsinki, Finland) was inserted
nasogastrically and placed at 55 cm from the tip of the nose. The catheter was attached
to an automated air tonometry device (Tonocap, Datex-Engstrom, Finland), which was
set up to measure intragastric PCO2 (PgCO2) every ten minutes.
A radial artery catheter was inserted in the non-dominant arm to allow arterial blood
sampling.
Baseline measurements of arterial blood and gastric tonometry PCO2 were obtained 10
minutes and immediately before the exercise period. The exercise period lasted 10
minutes and started immediately after the last baseline tonometric measurement cycle.
Exercise was performed on an electromagnetically braked bicycle ergometer (Lode,
Groningen, Netherlands). During the exercise test a 12-lead electrocardiogram was
recorded (Case 12, Marquette Electronics Inc., Milwaukee, USA) and breath-by-breath
oxygen uptake (VO2) and respiratory gas exchange ratio (RQ) were measured by a
respiratory gas analyzer system (Oxycon- Jaeger, Bunnik, the Netherlands). The
workload during was gradually increased and targeted at submaximal work rate level 12.
Arterial and tonometry parameters were obtained immediately at the end of the exercise
period. Ten and 20 minutes after the exercise period recovery measurements of arterial
blood gases and tonometry parameters were done. Arterial blood was analyzed
immediately for pH, PCO2, PO2, bicarbonate content, and base excess (BE) using a
standard blood gas analyzer (Radiometer ABL520, Copenhagen, Denmark).
Gastric-arterial PCO2 gradients (PCO2) were calculated: PCO2 = PgCO2 – PaCO2. The
normal upper threshold value forPCO2 was considered 0.8 kPa. The decrease in base
excess (BL-BE minus EX-BE) was used as a measure of exercise intensity. Exercise
tonometry testing was considered to be “positive” if 1) PgCO2 after exercise increased
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over baseline PgCO2, 2)PCO2 exceeded the threshold value of 0.8 kPa in exercise or
recovery measurements (provided that baseline measurements were normal), and 3)
exercise intensity was submaximal (BE-decrease <8 mmol/l).
Comparison of different algorithms
Four potential diagnostic approaches were considered for analysis:
1. to perform angiography only in patients with classic abdominal angina
2. to screen with duplex sonography and perform angiography after an abnormal or
unreliable test
3. to screen with gastric exercise tonometry and perform angiography after an abnormal
or unreliable test
4. to screen with both gastric exercise tonometry and duplex sonography and perform
angiography in those with at least one of these screening tests abnormal or unreliable.
Statistics
Values are given as mean ± SD unless otherwise stated. P-values < 0.05 were
considered statistically significant. Association between tonometry test result and the
presence or absence of stenosis and ischemia was tested using the Fisher exact test. The
diagnostic accuracy of duplex sonography and exercise tonometry testing for
symptomatic chronic ischemia were assessed by calculation of sensitivity, specificity,
positive and negative predictive values, as well as likelihood ratios.
RESULTS
Duplex ultrasonography
In 12/84 (18%) patients duplex was not reliable because flow measurement in one or
both vessels (CA alone in 6, CA and SMA in 6) was impossible due to insufficient
visualisation (intestinal gas, circumferential calcifications, or large abdominal wall-
splanchnic artery distance) or wide measurement angle. Consequently 72 splanchnic
duplex ultrasounds were interpretable.
In 24/72 both vessels had normal flow velocities and were regarded as “negative
duplex tests”. In 48/72, a “positive duplex” was found. Significant stenoses were found
in CA and SMA in 13 patients, in the CA alone in 29 and in the SMA alone in 3
patients. In 3 of these 72 patients duplex showed stenosis or occlusion in one vessel,
while the other vessel (CA in 2, SMA in 1) could not be visualized. This did not change
the classification however, as these patients were already considered “abnormal” based
on the stenosis in one vessel.
Gastric exercise tonometry
In 4 tests the exercise level was too high for reliable interpretation with base excess
decrease after exercise exceeding 8 mmol/l 12. In 54/80 gastric exercise tonometry was
normal, the remaining 26 were considered abnormal (“positive tonometry exercise
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test”) with a gastric-arterial PCO2 gradient >0.8 kPa, and an increase after exercise of
PgCO2 over baseline.
Angiography
Splanchnic arterial stenoses >50% were found in 34 patients: 22 had isolated CA-
stenosis, 3 had isolated SMA-stenosis, 7 had stenosis of both CA and SMA, and 2 had
stenosis of all three splanchnic vessels (CA, SMA, and IMA).
Final diagnosis
Initially, the working group categorised 32 patients as chronic mesenteric ischemia.
With 50 months (range 35-80 months) follow-up in 4 patients the diagnosis was
changed to asymptomatic stenosis. Thus, in 28 patients the diagnosis chronic ischemia
was confirmed and maintained on follow-up. Of these patients 12 had isolated CA-
stenosis, 3 had SMA stenosis, 6 had stenosis of CA and SMA, 2 had stenosis of all three
vessels and 5 had NOMI.
Analysis of work-up regimens / diagnostic strategies
1. Clinical presentation. The classical clinical presentation of abdominal angina (both
moderate to severe pain after food intake unexplained by other causes, and weight loss)
was present in 27/84 subjects. Of these 27 patients 12 had chronic mesenteric
ischemia. Sixteen patients with chronic ischemia had an “incomplete” clinical pre-
sentation: only moderate-severe postprandial pain but no or only mild weight loss in 9,
only weight loss but lacking postprandial pain in 2, and both lacking postprandial pain
and weight loss in 5. The latter patients did present with abdominal pain but this was
not typically food-intake-related. Ten patients with a “non-classical” presentation were
treated by either surgery or PTA/stent placement and were symptom free afterwards.
Using the classical presentation as the only criterion, 57% of all chronic ischemia
patients would have been missed.
2. Duplex ultrasound. Of the 12 patients in whom one or both vessels could not be
adequately visualized for flow measurements, 8 had stenosis (7 in CA and 1 in SMA),
and 5 of them had ischemia.
Of the 72 reliable duplex ultrasound tests, 25 patients had abnormal duplex, confirmed
by angiography (true-positive for stenosis). In 23 patients with abnormal flow velocities
on ultrasound, the angiography was normal (false-positive for stenosis). In 22 patients
normal vasculature on duplex ultrasound was confirmed by angiography (true-negative
for stenosis). In 2 patients duplex ultrasound was normal, but angiography showed
stenosis of the CA in both (false-negative for stenosis). The diagnostic accuracy of
duplex ultrasound is summarised in table 1.
If duplex ultrasound had been used as the only screening test, and both positive and
unreliable tests were followed by angiography, two patients with stenoses would have
been missed, and a total of four patients with ischemia would remain undiagnosed (one
with chronic ischemia due to splanchnic artery stenosis, three with NOMI). Thus, 14%
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of all patients with ischemia would have been missed, while 24 (=29%) angiographies
could have been avoided.
3. Tonometry. One of the four patients with a non-diagnostic gastric exercise tonometry
test was finally diagnosed as having chronic mesenteric ischemia. In ten patients gastric
exercise tonometry was abnormal but angiography showed normal vasculature. Five of
these had nonocclusive mesenteric ischemia (NOMI), leaving 5 false-positive
tonometry tests. If we had relied on tonometry as the only screening method, 6/28
(21%) patients with ischemia would have been missed (gastric exercise tonometry false-
negative for ischemia). 54 (64 %) angiographies would have been avoided.
Table 1. Sensitivity, specificity, positive and negative predictive value and likelihood
ratio for duplex sonography and tonometry in stenosis and ischemia.
sens = sensitivity, spec = specificity, PPV = positive predictive value, NPV = negative
predictive value, LR = likelihood ratio
4. Combined duplex ultrasound and tonometry. Screening by combining duplex ultrasound
and gastric exercise tonometry, only followed by angiography if one of the screening
test is not normal (i.e. abnormal or inconclusive), would have yielded no false negative
results (negative predictive value 100%; 95% confidence interval: 73%-100%). In all 26
of the 28 patients with chronic ischemia one or both screening tests was abnormal, in 1
both duplex ultrasound and gastric exercise tonometry were unreliable, in 1 duplex
ultrasound was unreliable and gastric exercise tonometry was normal. Combined
screening resulted in 38 false-positive results (either one or both tests abnormal or
unreliable). The approach of combined non-invasive screening would have resulted in
18 (= 21%) true-negative results and thus in not performing splanchnic arteriography in
these patients.
DISCUSSION
From this study it can be concluded that relying on only one screening test for
excluding chronic symptomatic gastrointestinal ischemia does not suffice. Using clinical
presentation as “trigger” and angiography as diagnostic tool, as currently advocated 2,
stenosis ischemia%
assessable
tests sens spec PPV NPV LR sens spec PPV NPV LR
duplex 86 93 49 52 92 1.8 81 39 35 83 1.3
tonometry 95 48 79 62 69 2.3 78 91 81 89 8.2
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would have resulted in detection of less then 50% of all patients with ischemia. Duplex
ultrasound has the limitation of incomplete assessability, the 15% of this study is in line
with literature 10. Still, relying on duplex alone would have resulted in 14% missed
ischemia, albeit only one (4%) with chronic mesenteric ischemia, reconfirming its
capability of stenosis detection. Tonometry with its unique capability of showing actual
ischemia (defined as inadequate blood flow for the metabolism) is not suitable as
primary screening alone with miss-rates of 21%. Combining duplex ultrasound, as best
stenosis screening tool, and exercise tonometry, as only available diagnostic test for
detecting ischemia, leads to very accurate detection of symptomatic chronic mesenteric
ischemia. Moreover, the latter may be used to separate chronic mesenteric ischemia
from asymptomatic stenosis and demonstrate NOMI.
It might be questioned whether our approach of combined screening methods resulted
only in diagnosing clinically insignificant cases of chronic ischemia. In other words: are
those with less typical complaints of any importance. This is not the case, as these less
typical presentation, 10 patients were treated by revascularisation and were free of
symptoms thereafter. Interestingly, a difference was noted between those with typical
abdominal angina and those with an “incomplete clinical picture”. The former seem to
present more advanced stages of gastrointestinal ischemia with 63% 2-3 vessel disease
compared to only 9% of 2-3 vessel disease in the latter group.
Most authors focused on more advanced disease and indeed reported typical presen-
tation in most patients while only few patients with single vessel disease 2. Therefore, it
seems that current literature on abdominal angina focuses on late stages of chronic
mesenteric ischemia, and consequently early presentation is relatively underappreciated.
This notion is supported by the delay of many years before diagnosis in most patients.
The extreme was a patient with CA stenosis, who developed a gastric ulcer 31 years
earlier, and had postprandial pain ever since, disappearing immediately after stent
placement. Thus, chronic gastrointestinal ischemia can be found in more than typical
abdominal angina, and should include patients with unexplained epigastric pain after
meals and exercise.
Several explanations may be postulated for the fact that one patient may have
complaints with only single vessel stenosis and others have minimal complaints with
much more extensive vascular pathology. As in functional disorders such as irritable
bowel syndrome and non-ulcer dyspepsia, visceral sensitivity may vary widely between
individuals and explain marked differences in susceptibility for abdominal symptoms.
Furthermore, collateral circulation may be extensive in the gastrointestinal vascular bed.
It may well be that in longstanding and slowly progressive multi-vessel disease
abundant collateral circulation has developed securing the gastrointestinal perfusion,
while in newly developed single vessel stenosis -and especially occlusion- no adequate
collateral circulation is present yet, thus giving rise to ischemic symptoms.
In some patients ischemia was diagnosed despite normal vascular anatomy. This was
suspected in 5 patients with typical clinical presentation and abnormal tonometry. In
these patients NOMI (non-occlusive mesenteric ischemia) or vasospasm is the most
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likely cause of symptoms (and abnormal tonometry). It is widely recognised that
tonometry is the optimal diagnostic for NOMI detection 8. NOMI can be seen as an
exaggeration of normal adaptive response to low flow states. In our patients, NOMI
was caused by cardiac failure in one patient. In the remaining four, splanchnic vascular
spasms were thought to occur giving resulting in recurrent episodes of ischemia. In two
of these patients abundant spasms were visualized during angiography, an otherwise
rare phenomenon. All four patients were treated with vasodilating medication and
showed remarkable and longstanding improvement of symptoms.
The introduction of new minimally invasive techniques including MR angiography, CT
angiography, and portal vein flow measurement, may improve screening -or definite
diagnosis- of ischemia. Combining MRA with portal flow measurement seems
attractive, although anatomic resolution of MRA is still inferior compared to state of
the art splanchnic artery angiography and assessment of collaterals and influence of
respiration is not possible. Portal flow increment after a meal may be considered a
function of splanchnic vessel reserve. To date, the clinical experience with the latter
technique is sparse. Whatever diagnostic tool is used, combining a diagnostic test aimed
at vascular morphology and/or blood flow with a diagnostic test for actual GI-
ischemia is in our opinion mandatory.
The present study demonstrates that suspicion for chronic gastrointestinal ischemia
should include patients with unexplained longstanding abdominal pain eventually
provoked by meals or exercise, in which other more common causes were excluded.
The approach of performing angiography only in patients with a high degree of clinical
suspicion would have resulted in missed diagnosis in over 50% in our cohort of
patients with chronic mesenteric ischemia. Combining non-invasive screening with
exercise tonometry and duplex ultrasonography in this cohort of patients has excellent
diagnostic accuracy, while still avoiding 21% of angiographies.
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This thesis investigates the role of gastrointestinal exercise tonometry as a functional
diagnostic test in patients suspected of chronic gastrointestinal ischemia. In contrast
with all other diagnostic modalities (angiography, duplex sonography, CT- and MR-
angiography) that only provide information about vessel anatomy, vessel patency or
blood flow, tonometry can actually demonstrate end-organ ischemia.
Measurement of gastrointestinal luminal to blood PCO2 by means of tonometry has
been shown to provide exactly that information: the presence or absence of ischemia.
Until now it is the only clinically feasible, i.e. minimally invasive and bedside, technique
for monitoring the adequacy of gastrointestinal (mucosal) perfusion in a wide variety of
conditions such as (hemorrhagic) shock, sepsis, trauma, pancreatitis, cardiovascular and
gastro-esophageal surgery. In chapter two a review of the current thoughts on
tonometry is given. Uncertainties about physiological background, methodology, and
clinical use have hindered tonometry from gaining the status of a routine diagnostic
technique. Most of the initial problems however have been addressed and solved, for
instance by the introduction of automated air tonometry, and recognizing that
measurements have to be done in an empty stomach and after adequate gastric acid
suppression.
Gastric tonometry after food provocation has been used as diagnostic test for chronic
gastrointestinal ischemia. This has resulted in varying and disappointing accuracies. In a
pilot study by J.J. Kolkman, using physical exercise as an alternative provocative
manoeuvre, gastric (saline) tonometry showed to be a promising test for the detection
of symptomatic chronic gastrointestinal ischemia. In chapters two, three and four of
this thesis questions arising from this pilot study are addressed, including the intensity
of exercise needed for provocation of gastrointestinal ischemia, the best way to monitor
this exercise intensity and the best location in the gastrointestinal tract for tonometric
measurements.
In chapter three the relationship between exercise intensity and gastric mucosal
perfusion adequacy as measured by gastric (air) tonometry is investigated in a volunteer
study with two different exercise levels. The results of this study show that in these
subjects with normal splanchnic vasculature, gastric ischemia can develop after only 10
minutes of (maximum) physical exercise. The intragastric-arterial PCO2 gradient
(PCO2) was elevated (by 1.1 ± 1.0 kPa) over baseline values (-0.1 ± 0.3 kPa) only after
maximal exercise (p<0.001). The development of gastric ischemia strongly depended
upon the exercise intensity: using Spearman’s rank test a positive correlation between
PCO2 and arterial lactate level, taken as an index of exercise intensity was found
(r=0.76, p<0.0001). By bilinear regression analysis, a lactate level of 12 mmol/L above
which a sharp rise in the PCO2 occurred, was calculated. Furthermore, this study
demonstrates that air tonometry can be used for assessment of the adequacy of gastric
mucosal perfusion during physical exercise.
As maximum exercise levels can lead to gastric mucosal ischemia in healthy subjects, in
patients suspected of chronic gastrointestinal ischemia the exercise build-up should be
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controlled to reach submaximal exercise levels, thus achieving maximal diagnostic
accuracy by avoiding false-positive tests. In chapter four three different monitoring
regimes (monitoring of heart rate, respiratory gas exchange ratio -RQ-, and rapid serial
arterial lactate measurements) for determining exercise intensity are compared. Exercise
levels above submaximal were reached in 20% of heart rate monitoring, 2% of RQ-
monitoring and 5% of rapid serial lactate measurements (p<0.05 for HR vs. RQ and
lactate). Low exercise levels were seen in 5%, 10% and 41% in heart rate monitoring,
RQ-monitoring, and rapid lactate monitoring, respectively (p<0.01 for lactate vs. heart
rate and RQ). However, low exercise levels did not result in an increase in false negative
tonometry tests (5% in low exercise level compared to 6% in all tests), whereas high
levels resulted in 43% false-positive tests (compared to 19% in all tests, p<0.001). RQ-
monitoring resulted in the greatest proportion of optimal exercise tests, but rapid serial
lactate emerged as our method of choice, combining good diagnostic accuracy, low-cost
and simplicity, and allowing accurate gastrointestinal exercise tonometry easily to be
performed in daily clinical practice.
In most patients with chronic gastrointestinal ischemia the celiac artery (CA) is stenotic
or occluded, either as the single vessel involved or in multivessel disease. This enables
the use of gastric exercise tonometry as a diagnostic function test. It may be questioned
whether jejunal tonometry measurement -in the flow region of the superior mesenteric
artery (SMA)- could have additive value in patients with (isolated) SMA stenosis or
occlusion. In chapter five we investigated the feasibility of combining gastric and
jejunal exercise tonometry and determined the normal values. Furthermore we
investigated the potential diagnostic value of combining gastric with jejunal exercise
tonometry.
This study demonstrated that combining gastric with jejunal exercise tonometry testing
is a feasible procedure that is relatively easy to perform. Normal resting jejunal PCO2
values were 0.8 kPa higher than gastric PCO2. The calculated normal upper threshold of
the jejunal-arterial PCO2 gradient is 1.4 kPa. This threshold was not exceeded during
and after exercise in subjects with normal splanchnic vasculature. Of 8 patients with
chronic gastrointestinal ischemia, gastric exercise tonometry was abnormal in five, both
gastric and jejunal tonometry were abnormal in one, and only jejunal exercise
tonometry was abnormal in two. Gastric exercise tonometry would thus have detected
6 of 8 patients, while jejunal tonometry alone would have detected only 3 of 8. Thus,
combining jejunal with gastric exercise tonometry may contribute to the diagnosis of
gastrointestinal ischemia. Apart from having an additional value in demonstrating
jejunal ischemia in subjects with chronic gastrointestinal ischemia, the technique may be
used to demonstrate ischemia in other disorders such as hemodynamic instability and
Crohn's disease.
In chapter six, gastric exercise tonometry testing is validated as a diagnostic tool in a
cohort of 102 patients with unexplained chronic abdominal symptoms, suspected for
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chronic gastrointestinal ischemia. The diagnostic workup included gastric exercise
tonometry and angiography. The diagnosis gastrointestinal ischemia was based on
consensus in a multidisciplinary working group, sustained on follow-up.
Gastrointestinal ischemia was diagnosed in 38 patients. In 33 chronic gastrointestinal
ischemia (with single vessel involvement in 20 (17 CA, 3 SMA), and multivessel disease
in 13). In 5 patients non-occlusive ischemia was found. Using ROC-analysis, gastric-
arterial PCO2 proved the best gastric exercise tonometry parameter. The criteria for
diagnosing ischemia were: PCO2 > 0.8 kPa, and increase of gastric PCO2 (with base
excess decrease < 8 mmol/l) during exercise. Using these criteria gastric exercise
tonometry had a sensitivity of 78% and specificity of 92% for diagnosing chronic
gastrointestinal ischemia. It is concluded that gastric exercise tonometry is an accurate
diagnostic tool to show gastrointestinal ischemia, both chronic splanchnic syndrome
and NOMI. Including gastric exercise tonometry in clinical decision making enabled
selecting patients with ischemia who benefited from vascular or medical treatment.
These benefits were sustained during 4-yr follow-up. Gastric exercise tonometry should
be considered in the work-up of patients suspected of gastrointestinal ischemia.
In chapter seven, various diagnostic approaches for suspected chronic mesenteric
ischemia are compared: 1) angiography, only in patients with classic abdominal angina,
2) screening with duplex sonography, angiography if sonography abnormal or
unreliable, 3) screening with gastric tonometry and angiography if tonometry not
normal, 4) both gastric tonometry exercise and duplex sonography, angiography if one
of both screening tests not normal.
In 28 of 84 patients suspected of chronic gastrointestinal ischemia and who underwent
both angiography, duplex sonography, and gastric exercise tonometry the consensus
diagnosis chronic gastrointestinal ischemia was made by an expert panel. Using clinical
suspicion only, 16 patients (57%) would have been missed. Screening by duplex
sonography or gastric tonometry alone would have missed 4 respectively 6 patients.
Screening with combined gastric tonometry and duplex sonography would not have
missed patients with symptomatic ischemia, while 21% of angiographies would have
been avoided. From this study it can be concluded that relying on only one screening
test for excluding chronic symptomatic gastrointestinal ischemia does not suffice. Using
clinical presentation as “trigger” and angiography as diagnostic tool, as currently
advocated, would have resulted in detection of less than 50% of all patients with
ischemia. Duplex ultrasound has the limitation of incomplete assessability (15% in this
study which is in line with literature). Still, relying on duplex sonography alone would
have resulted in 14% missed patients with ischemia, albeit only one (4%) with chronic
splanchnic syndrome, reconfirming its capability of stenosis detection. Tonometry with
its unique capability of showing actual ischemia (defined as inadequate blood flow for
the metabolism) is not suitable as primary screening alone with miss-rates of 21%.
Tonometry may be used to separate chronic mesenteric ischemia from asymptomatic
stenosis and to demonstrate NOMI. Combining duplex ultrasound, as best stenosis
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screening tool, and exercise tonometry, as currently the only available diagnostic test for
detecting ischemia, leads to very accurate detection of symptomatic chronic mesenteric
ischemia. Currently, the approach of combined screening by duplex sonography and
gastric exercise tonometry represents the best diagnostic work-up strategy in patients
with suspected chronic gastrointestinal ischemia.

Samenvatting en Conclusies
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In dit proefschrift wordt de rol onderzocht van inspanningstonometrie van de maag als
diagnostische functietest bij patiënten met verdenking op chronische maagdarm-
ischemie. Gastrointestinale tonometrie is tot op heden de enige klinisch toepasbare,
minimaal invasieve, ‘bedside’ techniek om de doorbloeding van het maagdarmkanaal te
beoordelen. In tegenstelling tot alle andere diagnostische tests bij verdenking op
vaatlijden van het maagdarmkanaal, zoals angiografie, duplex echografie, en CT- en
MRI-angiografie, die slechts informatie geven over vaatanatomie (stenose of occlusie)
en bloedstroom kan tonometrische bepaling van de luminale PCO2 informatie geven
over het aan of afwezig zijn van ischemie in het eindorgaan (maag- of darmslijmvlies).
Tonometrie van de maag wordt in de klinische praktijk onder meer gebruikt om de
adequaatheid van de mucosale perfusie van het maagdarmkanaal te beoordelen bij
bijvoorbeeld (hemorrhagische) shock, sepsis, trauma, pancreatitis, cardiovasculaire
chirurgie en slokdarm- en maagchirurgie. Door onduidelijkheid over de fysiologische
achtergrond, methodologie en klinische toepasbaarheid is tonometrie tot op heden
echter nog geen routinematig toegepaste techniek. In hoofdstuk 2 wordt een overzicht
gegeven over de huidige inzichten in tonometrie. In dit overzicht worden de
fysiologische en methodologische achtergronden besproken, evenals nieuwe ontwik-
kelingen zoals geautomatiseerde luchttonometrie (welke de arbeidsintensieve en fout-
gevoelige handmatige vloeistoftonometrie vervangt en tonometrie daarmee veel
eenvoudiger uitvoerbaar maakt), de waarde van de luminale-bloed PCO2 gradiënt versus
de intramucosale pH en de noodzaak van maagzuurremming en het meten in een lege
maag.
Tonometrie van de maag na maaltijdprovocatie is in het verleden gebruikt als
diagnostische test bij chronische maagdarmischemie. De resultaten hiervan waren
wisselend met vaak teleurstellende accuratesse van deze diagnostische test. Tonometrie
van de maag waarbij lichamelijke inspanning als alternatieve provocatietest voor
ischemie werd door Kolkman et al. in 1999 beschreven. De conclusie van deze pilot
studie was dat inspanningstonometrie van de maag een veelbelovende diagnostische
test voor symptomatische chronisch maagdarmischemie leek. In hoofdstukken twee,
drie en vier van dit proefschrift worden vragen die naar aanleiding van die pilot studie
rezen verder onderzocht. Welk inspanningsniveau is nodig voor provocatie van
gastrointestinale ischemie? Wat is de beste manier om de hoogte van dit
inspanningsniveau te bewaken? Wat is de beste plaats in het maagdarmkanaal voor
tonometrie?
In hoofdstuk 3 wordt de relatie onderzocht tussen het niveau van lichamelijk
inspanning en de doorbloeding van de maag zoals gemeten met (lucht-)tonometrie. Dit
werd onderzocht bij gezonde vrijwilligers tijdens twee verschillende inspanningsniveaus
(submaximaal en maximaal). De resultaten van deze studie laten zien dat bij gezonde
personen met normale maag- en darmvaten ischemie van de maag kan optreden na
slechts 10 minuten (maximale) inspanning. De intragastrische-arteriële PCO2 gradiënt
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(PCO2) was alleen bij maximale inspanning hoger (1.1 ± 1.0 kPa) dan baseline waarden
(-0.1 ± 0.3 kPa; p<0.001). Het optreden van ischemie van de maag hing sterk af van het
inspanningsniveau. Met behulp van Spearman’s rank test werd een positieve correlatie
tussen PCO2 arterieel lactaat (als maat voor inspanningsintensiteit) gevonden (r=0.76,
p<0.0001). Met bilineaire regressie analyse werd een lactaat van 12 mmol/L berekend,
waarboven een scherpe toename van PCO2 werd gezien.
Aangezien maximale inspanning kan leiden tot ischemie van de maag bij gezonde
personen, moet bij het gebruik van inspanningstonometrie van als diagnostische test bij
patiënten met verdenking op chronische gastrointestinale ischemie om vals-positieve
tests te voorkomen het inspanningsniveau zodanig gecontroleerd zijn dat dit
submaximaal blijf.
In hoofdstuk 4 worden drie verschillende manieren om het inspanningsniveau te
bewaken vergeleken: monitoring van hartfrequentie (HR), respiratoir quotiënt (RQ) en
snelle arteriële lactaatbepalingen. Aan de hand van meting van de hartfrequentie werd
bij 20% van de tests een inspanningsniveau boven submaximaal verkregen. Dit was
slechts 2% bij RQ-monitoring en 5% bij lactaatmetingen (p<0.05 voor HR vs. RQ en
lactaat). Een laag inspanningsniveau werd gevonden bij 5% van de HR-gemonitorde
tests, 10% bij RQ-monitoring en 41% bij lactaat monitoring (p<0.01 voor lactaat vs.
HR en RQ). Een laag inspanningsniveau resulteerde echter niet in een toename van
vals-negatieve tonometrietests (5% bij laag inspanningsniveau vergeleken met 6% in alle
tests). Te hoge inspanningsniveaus resulteerden daarentegen in 43% vals-positieve tests
(vergeleken met 19% in alle tests, p<0.001). RQ-monitoring resulteerde in de grootste
proportie van optimale inspanningstests, maar monitoring aan de hand van snelle
lactaatmetingen heeft toch onze voorkeur omdat dit in de dagelijkse praktijk eenvoudig
uitvoerbaar is, lage kosten heeft en een goede diagnostische accuratesse van
inspanningstonometrie van de maag oplevert.
Bij de meeste patiënten met chronisch splanchnicus syndroom is de truncus coeliacus
(CA) stenotisch of geoccludeerd, hetzij als enig betrokken vat, hetzij bij meertakslijden.
Dit maakt het mogelijk dat inspanningstonometrie van de maag wordt gebruikt als
diagnostische functietest. De vraag die zich dan aandient is of metingen in het jejunum
-in het stroomgebied van de arteria mesenterica superior (SMA)- wel of geen
meerwaarde hebben bij patiënten met (al dan niet geïsoleerde) SMA stenose. In
hoofdstuk 5 wordt de uitvoerbaarheid van gecombineerde maag- en jejunum-
tonometrie bij inspanning onderzocht en worden de normaalwaarden van inspannings-
tonometrie van het jejunum vastgesteld. Daarnaast werd de diagnostische waarde van
gecombineerde inspanningstonometrie van maag en jejunum onderzocht.
Gecombineerde inspanningstonometrie van maag en dunne darm bleek relatief
eenvoudig uitvoerbaar. De normale jejunum PCO2 waarde was in rust 0.8 kPa hoger dan
de maag PCO2. De berekende bovengrens van normaal van de jejunale-arteriële PCO2
gradiënt is 1.4 kPa. Bij personen met normale maag- en darmvasculatuur werd deze
bovengrens tijdens (en na) submaximale lichamelijke inspanning niet overschreden. Van
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acht patiënten met chronische gastrointestinale ischemia, was inspanningstonometrie
van alleen de maag afwijkend bij vijf, van zowel maag als jejunum bij één en van alleen
jejunum bij twee. Inspanningstonometrie van de maag alleen zou dus zes van de acht
patiënten hebben gedetecteerd, terwijl jejunumtonometrie alleen dit slecht bij drie van
de acht zou doen. Het combineren van metingen in het jejunum bij inspannings-
tonometrie van de maag kan dus bijdragen bij de diagnostiek van chronische intestinale
ischemie. Los van deze additionele waarde van het aantonen van jejunumischemie bij
patiënten met chronisch splanchnicus syndroom, kan deze techniek ook gebruikt
worden om ischemie aan te tonen bij andere aandoeningen zoals hemodynamische
instabiliteit en de ziekte van Crohn.
In hoofdstuk 6, wordt inspanningstonometrie van de maag gevalideerd als
diagnostische test in een cohort van 102 patiënten met onbegrepen chronische
buikklachten, verdacht voor chronische maagdarmischemie. Het diagnostische traject
omvatte naast inspanningstonometrie van de maag onder andere angiografie. De
consensusdiagnose chronische maagdarmischemie werd gesteld door een Multi-
disciplinaire werkgroep (expert panel), het beloop tijdens de follow-up periode werd
hierin betrokken. Chronische gastrointestinale ischemie werd gediagnostiseerd bij 38
patiënten. Bij 33 betrof het chronisch splanchnicus syndroom (met eentakslijden bij 20
patiënten (17 CA, 3 SMA), and meertakslijden bij 13). Bij 5 patiënten werd non-
occlusieve ischemie (NOMI) gevonden. Met behulp van ROC-analyse bleek dat de
intragastrische-arteriële PCO2 de beste parameter was voor inspanningstonometrie. De
criteria voor de diagnose ischemie waren: PCO2 > 0.8 kPa, een toename van
intragastrische PCO2 tijdens inspanning en submaximale inspanning met een base exces
afname < 8 mmol/l. Met deze criteria had inspanningstonometrie van de maag een
sensitiviteit van 78% en een specificiteit van 92% voor de diagnose van chronische
gastrointestinale ischemie. De conclusie van deze validatietest is dat inspanningstono-
metrie van de maag een accurate diagnostische test is om gastrointestinale ischemie aan
te tonen, zowel chronisch splanchnicus syndroom als NOMI. Wanneer inspannings-
tonometrie van de maag wordt betrokken bij “clinical decision making” is het mogelijk
om patiënten te selecteren die baat hebben bij vasculaire of medicamenteuze
behandeling, wat bleek tijdens de follow-up perioden van 4 jaar. Inspanningstonometrie
van de maag moet worden overwogen voor de work-up bij patiënten met verdenking
op chronische gastrointestinale ischemie.
In hoofdstuk 7, worden verschillende manieren van diagnostische aanpak bij
verdenking op chronische maagdarmischemie vergeleken: 1) angiografie, alleen bij
patiënten met klassieke angina abdominalis, 2) screening met duplex echografie en
angiografie alleen als duplex echo afwijkend of niet betrouwbaar, 3) screening met
inspanningstonometrie van de maag en angiografie als tonometrie niet normaal, 4)
zowel duplex echografie en inspanningstonometrie van de maag als screeningtests,
angiografie als een of beide screening tests niet normaal.
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Bij 28 van 84 patiënten met verdenking op chronische maagdarmischemie en die allen
zowel angiografie, duplex echografie en inspanningstonometrie van de maag
ondergingen werd de diagnose chronische maagdarmischemie in consensus gesteld
door een expert panel.
Wanneer de diagnose alleen op klinische criteria gesteld zou zijn, zou deze bij 16
patiënten (57%) zijn gemist. Screening door duplex echografie of maagtonometrie
alleen zou leiden tot een gemiste diagnose bij 4 respectievelijk 6 patiënten. Bij screening
met zowel maagtonometrie als duplex echografie zou bij geen van de patiënten met
symptomatische chronische maagdarmischemie de diagnose zijn gemist terwijl 21% van
de angiografieën niet nodig zou zijn geweest. Uit de resultaten van dit onderzoek kan
worden geconcludeerd dat één enkele screeningtest voor het uitsluiten van de diagnose
chronische symptomatische maagdarmischemie onvoldoende is. Een hoge klinische
verdenking en dan angiografie doen als diagnostische test, heden ten dage nog
algemeen gebruik, zou tot de diagnose hebben geleid bij minder dan 50% van alle
patiënten met chronische ischemie. Duplex echografie heeft als beperking dat het
onderzoek vrij vaak onvolledig te beoordelen is (15% in deze studie komt overeen met
data in de literatuur). Toch, hoewel bij screening met duplex echografie alleen 14% van
de patiënten met chronische ischemie gemist zouden zijn, zou slechts één patiënt (4%)
met chronisch splanchnicus syndroom zijn gemist. Dit bevestigt opnieuw het vermogen
van duplex echografie om stenoses aan te tonen. Tonometrie heeft het unieke
vermogen om daadwerkelijk ischemie aan te tonen, maar is niet geschikt als enige
screeningtest met een percentage gemiste diagnoses van 21%. Tonometrie kan gebruikt
worden om onderscheid te maken tussen symptomatisch maagdarmvaatlijden en
asymptomatische stenose en ook voor het aantonen van niet-occlusieve mesenteriaal
ischemie (NOMI). Het combineren van duplex echografie als beste screeningtest voor
stenoses en inspanningstonometrie van de maag als test om daadwerkelijk ischemie aan
te tonen, leidt tot een hoge accuratesse bij het diagnostiseren van chronische
maagdarmischemie. Momenteel is gecombineerde screening met duplex echografie en
inspanningstonometrie van de maag de beste diagnostische aanpak bij verdenking op
chronisch maagdarmvaatlijden.
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Voor hun bijdrage aan de totstandkoming van dit proefschrift ben ik velen dank
verschuldigd voor hun directe en indirecte steun. Een aantal mensen wil ik hier in het
bijzonder noemen.
Dr. J.J. Kolkman, beste Jeroen. Het zal in 1996 geweest zijn (“time flies…”) dat je
vanuit “het trappenhuis in de VU” naar Enschede kwam en je afvroeg of er ergens
ruimte zou zijn om inspanningstests te doen waarbij je met CO2-metingen in de maag
iets zou kunnen zeggen over de doorbloeding van die maag. Dat laatste snapte ik niet
echt, maar een plek voor inspanningsonderzoek kon ik “via via” natuurlijk wel regelen
en dus was ik voor ik het goed en wel besefte geklist als “onderzoeker”. Ik kreeg de
gelegenheid om tijdens mijn opleiding tot internist een researchstage te doen: het
vrijwilligersonderzoek. Eigenlijk was mijn doel “alleen maar” een “JAP-artikel” (om
Ellie te laten zien dat ook ik dat kan).
Maar daarna smaakte het naar meer. Dankzij jou kon ik na mijn opleiding in het MST
blijven als chef de clinique/onderzoeker. En jij hebt mij dat onderzoeker-zijn goed
bijgebracht: protocollen bedenken, onderzoeksvoorstellen door commissies loodsen,
het daadwerkelijke onderzoek uitvoeren: metingen doen (vaak leuk, soms heel erg leuk,
maar soms ook lastig, vooral als je bij patiënten teveel vervelende slangetjes moet
inbrengen), data verzamelen, bewerken en statistiek doen, en het uiteindelijke
opschrijven.
En al doende hadden we zomaar zoveel gedaan dat er “een boekje” van moest
komen… Jeroen, dank voor al wat je me geleerd hebt, voor je inzet, je onmetelijke
enthousiasme, en ook voor je geduld.
Prof.dr. E.J. Kuipers, beste Ernst. Mooi onderzoek doen in “de periferie” is één ding,
maar áls dat boekje er dan moet komen … heb je een echte professor nodig! Veel dank
ben ik je verschuldigd voor je geduldige begeleiding en voor het steeds weer kritisch
doorlezen van de manuscripten. Hoe vaak heb je niet - en dan ook nog in een mum van
tijd - de zwakheden in een stuk blootgelegd. Echt helemaal geweldig vind ik het dat je
kritiek nooit negatief maar altijd opbouwend was. Ernst, het is me een eer dat je mijn
promotor wilt zijn.
Dr. R.H. Geelkerken, dr. A.B. Huisman, leden van de werkgroep maagdarmischemie
van het Medisch Spectrum Twente. Beste Bob, beste Ad. Al heel snel kreeg ik van
Jeroen de taak om een werkgroep maagdarmischemie “op te richten”. Ik denk dat er
nog nooit zo snel een multidisciplinaire werkgroep is geformeerd. Eén telefoontje naar
ieder van jullie, vervolgens een briefje met datum en plaats van de eerste bijeenkomst
en de “WMI” was een feit. Zo zie je maar weer wat er allemaal mogelijk is als een paar
mensen dezelfde “drive” hebben. Tijdens de besprekingen heb ik veel geleerd van jullie
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evenals van de andere leden van de WMI. Verder ben ik jullie zeer erkentelijk voor de
bijdrage aan de onderzoeken en het schrijven van de diverse artikelen die de basis
vormen van dit proefschrift.
Prof.dr. A.B.J. Groeneveld, beste Johan, ik wil je danken voor de goede samenwerking
die geleid heeft tot hoofdstuk 2 en 3 van dit proefschrift. Je revisies kwamen altijd
pijlsnel.
Bijzondere dank voor de vrijwilligers van hoofdstuk 3, thans allen zelf dokter, voor hun
lijfelijke en soms zeer overmatige inspanning.
Veel dank ook voor het personeel van de longfunctieafdeling van het MST. Ik heb veel
patiënten “over de brug” meegenomen die bovendien lang op jullie afdeling moesten
verblijven voor alle rust-, inspannings- en herstelmetingen, maar nooit was jullie een
fietstest teveel. Het enthousiasme en de deskundigheid waarmee jullie de
inspanningstesten begeleidden en de bloedgassen (en in het begin ook de
“watergassen”), die altijd tussendoor en waarschijnlijk soms ook ongelegen kwamen,
bepaalden heb ik erg gewaardeerd.
Mijn dank gaat verder uit naar de assistentes van poli 53D (mijn polinr. in Terneuzen is
weer 53, alleen zonder D want het is een kleiner ziekenhuis), en het personeel van de
scopieafdeling en de interne afdelingen (vooral de Gb) van het MST voor al het extra
regelwerk wat van ze werd gevraagd voor de patiënten die voor tonometrietests
kwamen. Speciale dank voor Anja Goossens die later de patiëntenmetingen is gaan
doen en Peter Mensink die niet alleen de onderzoeksfakkel van mij overnam, maar mij
ook nog inhaalde.
Als ik geen internist was geworden, had ik dit onderzoek niet gedaan… Dr. M. van
Zoeren van het Militair Hospitaal in Utrecht leerde mij tijdens mijn senior-co-schappen
dat interne geneeskunde wél een prachtig vak kan zijn. Van de internisten van het
Ignatius Ziekenhuis in Breda waar ik “agnio” was leerde ik de beginselen van het vak.
Via via (dr. Evert Sanders en dr. Pieter Wismans bedankt!) kon ik naar het
Havenziekenhuis in Rotterdam, een opleidingsziekenhuis. Prof.dr. P.C. Stuiver wist mij
“door” de regionale opleidingscommissie te “lobbyen”, heel veel dank hiervoor. Later
werd dr. Sander Bauer m’n opleider in het Havenziekenhuis. Hem en de andere
internisten wil ik danken voor al wat ze me geleerd hebben. Evenzo dank aan dr. A.
Berghout, internist en opleider in het Zuiderziekenhuis te Rotterdam. Tenslotte dank
aan alle internisten en maag-, darm- en leverartsen van het Medisch Spectrum Twente
voor de kennis en vaardigheden die ik van ze heb mogen leren. Speciale dank aan dr.
Hein Jordans en Prof.dr. Dick Richel, m’n opleiders in Enschede. Dick, jij had de visie
om een “wetenschapsstage” in te voeren. Ziehier één van de resultaten daarvan…
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Verder wil ik al mijn collega-assistenten bedanken voor de prima tijd die we in de
respectievelijke ziekenhuizen hebben gehad. Bedankt Matthijs, Debbie, Huib, Ton,
Felix, Leon, Harmen, Nicole, Paul, Kalung, Paul, Albert, Rik, Leo, Gert, Sigga, Siska,
Sabine, Willem, Lieuwe, Jannekes, Henk-Jan (“sper”), “stra”, Jan, Edwin, en al wie ik
nu vergeet te noemen. De opleiding zou zonder jullie een stuk minder leuk zou zijn
geweest.
Ik dank mijn Terneuzen collega’s Wilfred Frijlink, Peter Houben, Jan van der Knaap,
Cecile Idink, Loek van Reisen, Jos Spijker, Inge Wauters en Anne Weenink voor de
geboden gelegenheid om het proefschrift af te ronden. Maten, bedankt!
Bijzonder veel dank ook voor Myriam Berkhout-Winne, “mijn” secretaresse in
Terneuzen. Myriam, de hoeveelheid werk die je verzet hebt zo vlak voor de promotie is
werkelijk geweldig. Zonder jou zou het niet gelukt zijn om alles op tijd rond te krijgen.
Cecile Idink en Bert Beishuizen, beiden paranimf, beiden collega, beiden ook vriendin
cq. vriend, en beiden - besef ik me nu ik dit opschrijf - afkomstig uit Enschede. Cecile,
door jouw enthousiaste verhalen ben ik in Zeeuws-Vlaanderen gaan kijken… en
gebleven. Bert, jammer dat je niet naar Zeeuws-Vlaanderen komt (maar ook wel een
beetje begrijpelijk…). Ik ben blij dat jullie mijn paranimfen zijn en wil jullie danken
voor jullie steun.
Mijn ouders wil ik danken voor alle mogelijkheden die ze me hebben geboden om te
studeren en hun geweldige en onvoorwaardelijke steun. Rie en Han sr., geweldig
bedankt.
En op de laatste maar niet de minste plaats wil ik Ellie en Marleen bedanken. Lieve
Marleen, toen ik in 1997 begon aan dit “werkstuk” besefte ik niet wat voor geweldigs er
later dat jaar nog zou gebeuren. Jouw geboorte is denk ik het mooiste wat me ooit in
mijn leven is overkomen. Je vrolijkheid en levenslust hebben me regelmatig opgebeurd.
Binnenkort kunnen we weer wat vaker gaan biken. Lieve Ellie, we zijn in elkaars kielzog
een aantal malen dwars door Nederland verhuisd. Nu wonen we bijna en werk jij
helemaal in België. Bedankt voor het toch altijd weer bieden van een stabiel en rustig
“thuisfront”, zonder dat zou ik het niet hebben kunnen afmaken. En je hulp bij de
laatste loodjes was onmisbaar.
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